<aiml version = "1.0.1" encoding = "UTF-8">
	<category>
		<pattern>* TEST *</pattern>
		<template>
			<think><set name = "topic">TEST</set></think>
			I know a lot about test
		</template>
	</category>
	<category>
		<pattern>TEST *</pattern>
		<template>
			<think><set name = "topic">TEST</set></think>
			I know a lot about test
		</template>
	</category>
	<category>
		<pattern>* TEST</pattern>
		<template>
			<think><set name = "topic">TEST</set></think>
			I know a lot about test
		</template>
	</category>
	<category>
		<pattern>TEST</pattern>
		<template>
			<think><set name = "topic">TEST</set></think>
			I know a lot about test
		</template>
	</category>
	<topic name = "TEST">
		<category>
			<pattern>* BE * MR. MOLERA *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * MR. MOLERA *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE MR. MOLERA *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE MR. MOLERA</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * MR. MOLERA</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE MR. MOLERA *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * MR. MOLERA</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE MR. MOLERA</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * ROUGHLY 70,000 RECENT LAW SCHOOL GRADUATES *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * ROUGHLY 70,000 RECENT LAW SCHOOL GRADUATES *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE ROUGHLY 70,000 RECENT LAW SCHOOL GRADUATES *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE ROUGHLY 70,000 RECENT LAW SCHOOL GRADUATES</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * ROUGHLY 70,000 RECENT LAW SCHOOL GRADUATES</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE ROUGHLY 70,000 RECENT LAW SCHOOL GRADUATES *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * ROUGHLY 70,000 RECENT LAW SCHOOL GRADUATES</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE ROUGHLY 70,000 RECENT LAW SCHOOL GRADUATES</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * WHO *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * WHO *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE WHO *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE WHO</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * WHO</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE WHO *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * WHO</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE WHO</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE BAR *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE BAR *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE BAR *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE BAR</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE BAR</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE BAR *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE BAR</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE BAR</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THOUSANDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THOUSANDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THOUSANDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THOUSANDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THOUSANDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THOUSANDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THOUSANDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THOUSANDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * OTHERS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * OTHERS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE OTHERS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE OTHERS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * OTHERS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE OTHERS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * OTHERS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE OTHERS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * LICENSING EXAMS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * LICENSING EXAMS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE LICENSING EXAMS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE LICENSING EXAMS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * LICENSING EXAMS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE LICENSING EXAMS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * LICENSING EXAMS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE LICENSING EXAMS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * SOCIAL WORK *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * SOCIAL WORK *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE SOCIAL WORK *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE SOCIAL WORK</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * SOCIAL WORK</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE SOCIAL WORK *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * SOCIAL WORK</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE SOCIAL WORK</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * ENGINEERING *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * ENGINEERING *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE ENGINEERING *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE ENGINEERING</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * ENGINEERING</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE ENGINEERING *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * ENGINEERING</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE ENGINEERING</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * SURGERY *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * SURGERY *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE SURGERY *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE SURGERY</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * SURGERY</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE SURGERY *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * SURGERY</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE SURGERY</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * OTHER FIELDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * OTHER FIELDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE OTHER FIELDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE OTHER FIELDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * OTHER FIELDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE OTHER FIELDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * OTHER FIELDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE OTHER FIELDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * HUNDREDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * HUNDREDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE HUNDREDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE HUNDREDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * HUNDREDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE HUNDREDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * HUNDREDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE HUNDREDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * OTHER STUDENTS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * OTHER STUDENTS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE OTHER STUDENTS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE OTHER STUDENTS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * OTHER STUDENTS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE OTHER STUDENTS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * OTHER STUDENTS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE OTHER STUDENTS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * CROWDED ROOMS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * CROWDED ROOMS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE CROWDED ROOMS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE CROWDED ROOMS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * CROWDED ROOMS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE CROWDED ROOMS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * CROWDED ROOMS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE CROWDED ROOMS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * UNIVERSITIES *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * UNIVERSITIES *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE UNIVERSITIES *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE UNIVERSITIES</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * UNIVERSITIES</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE UNIVERSITIES *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * UNIVERSITIES</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE UNIVERSITIES</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * TESTING CENTERS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * TESTING CENTERS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE TESTING CENTERS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE TESTING CENTERS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * TESTING CENTERS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE TESTING CENTERS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * TESTING CENTERS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE TESTING CENTERS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * THOSE EXAMS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * THOSE EXAMS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE THOSE EXAMS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE THOSE EXAMS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * THOSE EXAMS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE THOSE EXAMS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * THOSE EXAMS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE THOSE EXAMS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * TESTING SITES *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * TESTING SITES *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE TESTING SITES *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE TESTING SITES</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * TESTING SITES</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE TESTING SITES *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * TESTING SITES</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE TESTING SITES</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * THE SPRING *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * THE SPRING *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE THE SPRING *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE THE SPRING</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * THE SPRING</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE THE SPRING *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * THE SPRING</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE THE SPRING</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * THE CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * THE CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE THE CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE THE CORONAVIRUS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * THE CORONAVIRUS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE THE CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * THE CORONAVIRUS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE THE CORONAVIRUS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * THE COUNTRY *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * THE COUNTRY *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE THE COUNTRY *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE THE COUNTRY</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * THE COUNTRY</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE THE COUNTRY *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * THE COUNTRY</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE THE COUNTRY</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * RECENT GRADUATES *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * RECENT GRADUATES *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE RECENT GRADUATES *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE RECENT GRADUATES</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * RECENT GRADUATES</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE RECENT GRADUATES *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * RECENT GRADUATES</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE RECENT GRADUATES</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * THE START *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * THE START *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE THE START *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE THE START</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * THE START</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE THE START *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * THE START</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE THE START</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * THEIR CAREERS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * THEIR CAREERS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE THEIR CAREERS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE THEIR CAREERS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE * THEIR CAREERS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSTPONE THEIR CAREERS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE * THEIR CAREERS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSTPONE THEIR CAREERS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * OTHER STATES *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * OTHER STATES *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE OTHER STATES *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE OTHER STATES</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * OTHER STATES</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE OTHER STATES *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * OTHER STATES</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE OTHER STATES</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * THEM *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * THEM *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE THEM *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE THEM</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * THEM</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE THEM *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * THEM</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE THEM</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * PERSON *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * PERSON *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE PERSON *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE PERSON</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * PERSON</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE PERSON *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * PERSON</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE PERSON</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * CONCERN *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * CONCERN *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE CONCERN *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE CONCERN</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * CONCERN</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE CONCERN *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * CONCERN</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE CONCERN</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * THE POSSIBLE SPREAD *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * THE POSSIBLE SPREAD *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE THE POSSIBLE SPREAD *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE THE POSSIBLE SPREAD</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * THE POSSIBLE SPREAD</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE THE POSSIBLE SPREAD *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * THE POSSIBLE SPREAD</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE THE POSSIBLE SPREAD</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * THE VIRUS *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * THE VIRUS *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE THE VIRUS *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE THE VIRUS</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * THE VIRUS</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE THE VIRUS *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * THE VIRUS</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE THE VIRUS</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * TESTING CENTERS *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * TESTING CENTERS *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE TESTING CENTERS *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE TESTING CENTERS</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * TESTING CENTERS</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE TESTING CENTERS *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * TESTING CENTERS</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE TESTING CENTERS</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * THE ONE *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * THE ONE *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE THE ONE *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE THE ONE</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * THE ONE</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE THE ONE *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * THE ONE</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE THE ONE</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * MR. MOLERA *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * MR. MOLERA *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE MR. MOLERA *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE MR. MOLERA</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * MR. MOLERA</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE MR. MOLERA *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * MR. MOLERA</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE MR. MOLERA</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * HIS EXAM *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * HIS EXAM *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE HIS EXAM *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE HIS EXAM</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * HIS EXAM</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE HIS EXAM *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * HIS EXAM</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE HIS EXAM</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * THE UNIVERSITY *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * THE UNIVERSITY *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE THE UNIVERSITY *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE THE UNIVERSITY</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * THE UNIVERSITY</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE THE UNIVERSITY *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * THE UNIVERSITY</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE THE UNIVERSITY</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * DENVER *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * DENVER *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE DENVER *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE DENVER</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE * DENVER</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONTINUE DENVER *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE * DENVER</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONTINUE DENVER</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * THE CHAOS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * THE CHAOS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP THE CHAOS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP THE CHAOS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * THE CHAOS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP THE CHAOS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * THE CHAOS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP THE CHAOS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * CONFUSION *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * CONFUSION *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP CONFUSION *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP CONFUSION</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * CONFUSION</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP CONFUSION *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * CONFUSION</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP CONFUSION</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * FUEL EFFORTS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * FUEL EFFORTS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP FUEL EFFORTS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP FUEL EFFORTS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * FUEL EFFORTS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP FUEL EFFORTS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * FUEL EFFORTS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP FUEL EFFORTS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * SOME STATES *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * SOME STATES *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP SOME STATES *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP SOME STATES</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * SOME STATES</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP SOME STATES *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * SOME STATES</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP SOME STATES</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * THE BAR *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * THE BAR *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP THE BAR *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP THE BAR</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * THE BAR</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP THE BAR *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * THE BAR</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP THE BAR</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * OTHER LICENSING EXAMS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * OTHER LICENSING EXAMS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP OTHER LICENSING EXAMS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP OTHER LICENSING EXAMS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * OTHER LICENSING EXAMS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP OTHER LICENSING EXAMS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * OTHER LICENSING EXAMS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP OTHER LICENSING EXAMS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * SOME CRITICS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * SOME CRITICS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP SOME CRITICS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP SOME CRITICS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * SOME CRITICS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP SOME CRITICS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * SOME CRITICS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP SOME CRITICS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * ADMINISTRATORS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * ADMINISTRATORS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP ADMINISTRATORS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP ADMINISTRATORS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * ADMINISTRATORS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP ADMINISTRATORS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * ADMINISTRATORS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP ADMINISTRATORS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * THEM *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * THEM *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP THEM *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP THEM</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * THEM</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP THEM *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * THEM</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP THEM</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * A NEEDED PROTECTION *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * A NEEDED PROTECTION *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP A NEEDED PROTECTION *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP A NEEDED PROTECTION</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * A NEEDED PROTECTION</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP A NEEDED PROTECTION *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * A NEEDED PROTECTION</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP A NEEDED PROTECTION</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * THE PUBLIC *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * THE PUBLIC *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP THE PUBLIC *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP THE PUBLIC</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP * THE PUBLIC</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HELP THE PUBLIC *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP * THE PUBLIC</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HELP THE PUBLIC</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * 23 STATES *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * 23 STATES *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO 23 STATES *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO 23 STATES</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * 23 STATES</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO 23 STATES *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * 23 STATES</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO 23 STATES</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * PERSON *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * PERSON *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO PERSON *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO PERSON</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * PERSON</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO PERSON *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * PERSON</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO PERSON</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * JULY *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * JULY *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO JULY *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO JULY</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * JULY</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO JULY *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * JULY</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO JULY</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * THEM *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * THEM *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO THEM *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO THEM</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * THEM</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO THEM *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * THEM</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO THEM</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * THE FALL *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * THE FALL *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO THE FALL *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO THE FALL</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * THE FALL</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO THE FALL *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * THE FALL</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO THE FALL</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * SOME OFFERING *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * SOME OFFERING *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO SOME OFFERING *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO SOME OFFERING</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * SOME OFFERING</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO SOME OFFERING *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * SOME OFFERING</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO SOME OFFERING</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * A NEW REMOTE OPTION *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * A NEW REMOTE OPTION *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO A NEW REMOTE OPTION *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO A NEW REMOTE OPTION</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * A NEW REMOTE OPTION</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO A NEW REMOTE OPTION *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * A NEW REMOTE OPTION</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO A NEW REMOTE OPTION</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * OCTOBER *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * OCTOBER *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO OCTOBER *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO OCTOBER</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO * OCTOBER</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GO OCTOBER *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO * OCTOBER</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GO OCTOBER</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * TESTING DATA *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * TESTING DATA *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE TESTING DATA *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE TESTING DATA</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * TESTING DATA</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE TESTING DATA *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * TESTING DATA</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE TESTING DATA</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE US *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE US *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE US *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE US</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE US</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE US *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE US</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE US</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * FAIR ACCESS *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * FAIR ACCESS *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE FAIR ACCESS *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE FAIR ACCESS</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * FAIR ACCESS</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE FAIR ACCESS *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * FAIR ACCESS</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE FAIR ACCESS</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * HEALTH HEALTH EQUITY *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * HEALTH HEALTH EQUITY *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE HEALTH HEALTH EQUITY *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE HEALTH HEALTH EQUITY</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * HEALTH HEALTH EQUITY</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE HEALTH HEALTH EQUITY *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * HEALTH HEALTH EQUITY</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE HEALTH HEALTH EQUITY</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * EVERYONE *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * EVERYONE *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE EVERYONE *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE EVERYONE</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * EVERYONE</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE EVERYONE *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * EVERYONE</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE EVERYONE</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE OPPORTUNITY *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE OPPORTUNITY *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE OPPORTUNITY *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE OPPORTUNITY</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE OPPORTUNITY</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE OPPORTUNITY *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE OPPORTUNITY</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE OPPORTUNITY</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT * LONG-STANDING SYSTEMIC HEALTH AND SOCIAL INEQUITIES *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT * LONG-STANDING SYSTEMIC HEALTH AND SOCIAL INEQUITIES *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT LONG-STANDING SYSTEMIC HEALTH AND SOCIAL INEQUITIES *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT LONG-STANDING SYSTEMIC HEALTH AND SOCIAL INEQUITIES</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT * LONG-STANDING SYSTEMIC HEALTH AND SOCIAL INEQUITIES</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT LONG-STANDING SYSTEMIC HEALTH AND SOCIAL INEQUITIES *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT * LONG-STANDING SYSTEMIC HEALTH AND SOCIAL INEQUITIES</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT LONG-STANDING SYSTEMIC HEALTH AND SOCIAL INEQUITIES</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT * MANY RACIAL AND ETHNIC MINORITY GROUPS *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT * MANY RACIAL AND ETHNIC MINORITY GROUPS *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT MANY RACIAL AND ETHNIC MINORITY GROUPS *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT MANY RACIAL AND ETHNIC MINORITY GROUPS</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT * MANY RACIAL AND ETHNIC MINORITY GROUPS</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT MANY RACIAL AND ETHNIC MINORITY GROUPS *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT * MANY RACIAL AND ETHNIC MINORITY GROUPS</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT MANY RACIAL AND ETHNIC MINORITY GROUPS</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT * INCREASED RISK *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT * INCREASED RISK *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT INCREASED RISK *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT INCREASED RISK</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT * INCREASED RISK</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT INCREASED RISK *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT * INCREASED RISK</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT INCREASED RISK</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT * COVID-19 *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT * COVID-19 *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT COVID-19 *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT COVID-19</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT * COVID-19</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUT COVID-19 *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT * COVID-19</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUT COVID-19</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * THE SPREAD *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * THE SPREAD *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK THE SPREAD *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK THE SPREAD</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * THE SPREAD</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK THE SPREAD *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * THE SPREAD</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK THE SPREAD</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * COVID-19 *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * COVID-19 *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK COVID-19 *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK COVID-19</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * COVID-19</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK COVID-19 *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * COVID-19</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK COVID-19</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * GREATER HEALTH EQUITY *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * GREATER HEALTH EQUITY *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK GREATER HEALTH EQUITY *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK GREATER HEALTH EQUITY</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * GREATER HEALTH EQUITY</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK GREATER HEALTH EQUITY *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * GREATER HEALTH EQUITY</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK GREATER HEALTH EQUITY</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * WE *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * WE *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK WE *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK WE</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * WE</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK WE *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * WE</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK WE</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * RESOURCES *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * RESOURCES *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK RESOURCES *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK RESOURCES</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * RESOURCES</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK RESOURCES *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * RESOURCES</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK RESOURCES</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * PHYSICAL AND MENTAL HEALTH *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * PHYSICAL AND MENTAL HEALTH *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK PHYSICAL AND MENTAL HEALTH *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK PHYSICAL AND MENTAL HEALTH</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * PHYSICAL AND MENTAL HEALTH</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK PHYSICAL AND MENTAL HEALTH *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * PHYSICAL AND MENTAL HEALTH</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK PHYSICAL AND MENTAL HEALTH</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * EASY ACCESS *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * EASY ACCESS *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK EASY ACCESS *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK EASY ACCESS</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * EASY ACCESS</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK EASY ACCESS *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * EASY ACCESS</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK EASY ACCESS</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * INFORMATION *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * INFORMATION *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK INFORMATION *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK INFORMATION</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * INFORMATION</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK INFORMATION *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * INFORMATION</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK INFORMATION</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * AFFORDABLE TESTING *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * AFFORDABLE TESTING *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK AFFORDABLE TESTING *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK AFFORDABLE TESTING</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * AFFORDABLE TESTING</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK AFFORDABLE TESTING *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * AFFORDABLE TESTING</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK AFFORDABLE TESTING</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * MEDICAL AND MENTAL HEALTH CARE *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * MEDICAL AND MENTAL HEALTH CARE *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK MEDICAL AND MENTAL HEALTH CARE *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK MEDICAL AND MENTAL HEALTH CARE</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * MEDICAL AND MENTAL HEALTH CARE</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK MEDICAL AND MENTAL HEALTH CARE *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * MEDICAL AND MENTAL HEALTH CARE</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK MEDICAL AND MENTAL HEALTH CARE</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO * WHAT *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO * WHAT *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO WHAT *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO WHAT</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO * WHAT</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO WHAT *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO * WHAT</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO WHAT</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO * WE *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO * WE *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO WE *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO WE</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO * WE</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO WE *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO * WE</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO WE</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO * HEALTH EQUITY CDC COVID-19 RESPONSE HEALTH EQUITY STRATEGY NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO * HEALTH EQUITY CDC COVID-19 RESPONSE HEALTH EQUITY STRATEGY NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO HEALTH EQUITY CDC COVID-19 RESPONSE HEALTH EQUITY STRATEGY NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO HEALTH EQUITY CDC COVID-19 RESPONSE HEALTH EQUITY STRATEGY NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO * HEALTH EQUITY CDC COVID-19 RESPONSE HEALTH EQUITY STRATEGY NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO HEALTH EQUITY CDC COVID-19 RESPONSE HEALTH EQUITY STRATEGY NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO * HEALTH EQUITY CDC COVID-19 RESPONSE HEALTH EQUITY STRATEGY NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO HEALTH EQUITY CDC COVID-19 RESPONSE HEALTH EQUITY STRATEGY NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO * IMMUNIZATION *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO * IMMUNIZATION *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO IMMUNIZATION *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO IMMUNIZATION</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO * IMMUNIZATION</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO IMMUNIZATION *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO * IMMUNIZATION</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO IMMUNIZATION</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO * RESPIRATORY DISEASES *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO * RESPIRATORY DISEASES *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO RESPIRATORY DISEASES *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO RESPIRATORY DISEASES</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO * RESPIRATORY DISEASES</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DO RESPIRATORY DISEASES *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO * RESPIRATORY DISEASES</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DO RESPIRATORY DISEASES</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * CDC *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * CDC *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT CDC *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT CDC</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * CDC</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT CDC *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * CDC</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT CDC</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * THIS CRITICAL WORK *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * THIS CRITICAL WORK *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT THIS CRITICAL WORK *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT THIS CRITICAL WORK</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * THIS CRITICAL WORK</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT THIS CRITICAL WORK *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * THIS CRITICAL WORK</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT THIS CRITICAL WORK</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * GUIDANCE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * GUIDANCE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT GUIDANCE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT GUIDANCE</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * GUIDANCE</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT GUIDANCE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * GUIDANCE</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT GUIDANCE</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * LONG-TERM CARE AND NURSING HOMES CONTENT *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * LONG-TERM CARE AND NURSING HOMES CONTENT *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT LONG-TERM CARE AND NURSING HOMES CONTENT *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT LONG-TERM CARE AND NURSING HOMES CONTENT</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * LONG-TERM CARE AND NURSING HOMES CONTENT</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT LONG-TERM CARE AND NURSING HOMES CONTENT *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * LONG-TERM CARE AND NURSING HOMES CONTENT</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT LONG-TERM CARE AND NURSING HOMES CONTENT</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * NON-CDC TOOLS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * NON-CDC TOOLS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT NON-CDC TOOLS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT NON-CDC TOOLS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * NON-CDC TOOLS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT NON-CDC TOOLS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * NON-CDC TOOLS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT NON-CDC TOOLS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * THIS SITE *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * THIS SITE *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT THIS SITE *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT THIS SITE</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * THIS SITE</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT THIS SITE *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * THIS SITE</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT THIS SITE</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * INFORMATIONAL PURPOSES *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * INFORMATIONAL PURPOSES *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT INFORMATIONAL PURPOSES *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT INFORMATIONAL PURPOSES</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * INFORMATIONAL PURPOSES</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT INFORMATIONAL PURPOSES *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * INFORMATIONAL PURPOSES</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT INFORMATIONAL PURPOSES</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * ENDORSEMENT *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * ENDORSEMENT *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT ENDORSEMENT *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT ENDORSEMENT</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * ENDORSEMENT</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT ENDORSEMENT *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * ENDORSEMENT</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT ENDORSEMENT</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * THE TOOLS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * THE TOOLS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT THE TOOLS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT THE TOOLS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * THE TOOLS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT THE TOOLS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * THE TOOLS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT THE TOOLS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * INFORMATION *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * INFORMATION *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE INFORMATION *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE INFORMATION</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * INFORMATION</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE INFORMATION *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * INFORMATION</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE INFORMATION</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THIS SITE *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THIS SITE *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THIS SITE *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THIS SITE</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THIS SITE</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THIS SITE *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THIS SITE</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THIS SITE</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * USERS *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * USERS *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE USERS *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE USERS</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * USERS</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE USERS *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * USERS</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE USERS</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THEIR OWN DETERMINATION *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THEIR OWN DETERMINATION *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THEIR OWN DETERMINATION *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THEIR OWN DETERMINATION</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THEIR OWN DETERMINATION</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THEIR OWN DETERMINATION *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THEIR OWN DETERMINATION</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THEIR OWN DETERMINATION</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THEIR EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THEIR EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THEIR EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THEIR EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THEIR EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THEIR EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THEIR EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THEIR EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * SEVERAL OTHER FEDERAL AGENCIES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * SEVERAL OTHER FEDERAL AGENCIES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT SEVERAL OTHER FEDERAL AGENCIES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT SEVERAL OTHER FEDERAL AGENCIES</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * SEVERAL OTHER FEDERAL AGENCIES</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT SEVERAL OTHER FEDERAL AGENCIES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * SEVERAL OTHER FEDERAL AGENCIES</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT SEVERAL OTHER FEDERAL AGENCIES</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * THIS CRITICAL EFFORT *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * THIS CRITICAL EFFORT *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT THIS CRITICAL EFFORT *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT THIS CRITICAL EFFORT</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * THIS CRITICAL EFFORT</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT THIS CRITICAL EFFORT *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * THIS CRITICAL EFFORT</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT THIS CRITICAL EFFORT</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * RESOURCES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * RESOURCES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT RESOURCES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT RESOURCES</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * RESOURCES</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT RESOURCES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * RESOURCES</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT RESOURCES</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION LIST *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION LIST *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION LIST *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION LIST</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION LIST</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION LIST *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION LIST</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION LIST</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * WORKERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * WORKERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT WORKERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT WORKERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * WORKERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT WORKERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * WORKERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT WORKERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * EMPLOYERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * EMPLOYERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT EMPLOYERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT EMPLOYERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * EMPLOYERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT EMPLOYERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * EMPLOYERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT EMPLOYERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * DIVERSE FIELDS/SETTINGS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * DIVERSE FIELDS/SETTINGS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT DIVERSE FIELDS/SETTINGS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT DIVERSE FIELDS/SETTINGS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * DIVERSE FIELDS/SETTINGS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT DIVERSE FIELDS/SETTINGS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * DIVERSE FIELDS/SETTINGS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT DIVERSE FIELDS/SETTINGS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * VARIOUS OTHER ORGANIZATIONS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * VARIOUS OTHER ORGANIZATIONS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT VARIOUS OTHER ORGANIZATIONS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT VARIOUS OTHER ORGANIZATIONS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * VARIOUS OTHER ORGANIZATIONS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT VARIOUS OTHER ORGANIZATIONS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * VARIOUS OTHER ORGANIZATIONS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT VARIOUS OTHER ORGANIZATIONS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * TRAINING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * TRAINING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT TRAINING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT TRAINING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * TRAINING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT TRAINING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * TRAINING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT TRAINING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * OTHER RESOURCES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * OTHER RESOURCES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT OTHER RESOURCES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT OTHER RESOURCES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * OTHER RESOURCES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT OTHER RESOURCES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * OTHER RESOURCES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT OTHER RESOURCES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE * AMERICAN COLLEGE *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE * AMERICAN COLLEGE *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE AMERICAN COLLEGE *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE AMERICAN COLLEGE</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE * AMERICAN COLLEGE</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE AMERICAN COLLEGE *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE * AMERICAN COLLEGE</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE AMERICAN COLLEGE</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE * EMERGENCY PHYSICIANS COVID-19 FIELD *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE * EMERGENCY PHYSICIANS COVID-19 FIELD *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE EMERGENCY PHYSICIANS COVID-19 FIELD *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE EMERGENCY PHYSICIANS COVID-19 FIELD</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE * EMERGENCY PHYSICIANS COVID-19 FIELD</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE EMERGENCY PHYSICIANS COVID-19 FIELD *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE * EMERGENCY PHYSICIANS COVID-19 FIELD</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE EMERGENCY PHYSICIANS COVID-19 FIELD</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE * AMERICAN ACADEMY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE * AMERICAN ACADEMY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE AMERICAN ACADEMY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE AMERICAN ACADEMY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE * AMERICAN ACADEMY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE AMERICAN ACADEMY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE * AMERICAN ACADEMY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE AMERICAN ACADEMY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE * PEDIATRICS TELEHEALTH PAYER POLICY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE * PEDIATRICS TELEHEALTH PAYER POLICY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE PEDIATRICS TELEHEALTH PAYER POLICY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE PEDIATRICS TELEHEALTH PAYER POLICY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE * PEDIATRICS TELEHEALTH PAYER POLICY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE PEDIATRICS TELEHEALTH PAYER POLICY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE * PEDIATRICS TELEHEALTH PAYER POLICY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE PEDIATRICS TELEHEALTH PAYER POLICY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE * RESPONSE *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE * RESPONSE *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE RESPONSE *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE RESPONSE</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE * RESPONSE</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE RESPONSE *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE * RESPONSE</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE RESPONSE</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE * COVID-19 SOCIETY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE * COVID-19 SOCIETY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE COVID-19 SOCIETY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE COVID-19 SOCIETY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE * COVID-19 SOCIETY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE COVID-19 SOCIETY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE * COVID-19 SOCIETY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE COVID-19 SOCIETY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE * CRITICAL *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE * CRITICAL *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE CRITICAL *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE CRITICAL</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE * CRITICAL</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDE CRITICAL *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE * CRITICAL</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDE CRITICAL</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * COVID-19 RESOURCE CENTER *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * COVID-19 RESOURCE CENTER *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE COVID-19 RESOURCE CENTER *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE COVID-19 RESOURCE CENTER</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * COVID-19 RESOURCE CENTER</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE COVID-19 RESOURCE CENTER *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * COVID-19 RESOURCE CENTER</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE COVID-19 RESOURCE CENTER</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * LITERATURE *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * LITERATURE *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE LITERATURE *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE LITERATURE</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * LITERATURE</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE LITERATURE *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * LITERATURE</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE LITERATURE</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * TRAINING *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * TRAINING *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE TRAINING *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE TRAINING</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * TRAINING</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE TRAINING *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * TRAINING</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE TRAINING</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * PAGES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * PAGES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND PAGES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND PAGES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * PAGES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND PAGES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * PAGES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND PAGES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * THE LANGUAGE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * THE LANGUAGE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND THE LANGUAGE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND THE LANGUAGE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * THE LANGUAGE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND THE LANGUAGE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * THE LANGUAGE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND THE LANGUAGE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * YOU *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * YOU *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND YOU *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND YOU</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * YOU</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND YOU *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * YOU</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND YOU</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * RESULT URLS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * RESULT URLS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND RESULT URLS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND RESULT URLS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * RESULT URLS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND RESULT URLS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * RESULT URLS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND RESULT URLS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * THIS TERM *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * THIS TERM *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND THIS TERM *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND THIS TERM</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * THIS TERM</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND THIS TERM *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * THIS TERM</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND THIS TERM</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * RESULTS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * RESULTS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND RESULTS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND RESULTS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * RESULTS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND RESULTS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * RESULTS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND RESULTS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * THESE GIVEN DATES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * THESE GIVEN DATES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND THESE GIVEN DATES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND THESE GIVEN DATES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * THESE GIVEN DATES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND THESE GIVEN DATES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * THESE GIVEN DATES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND THESE GIVEN DATES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * TESTING DATA *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * TESTING DATA *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND TESTING DATA *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND TESTING DATA</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * TESTING DATA</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND TESTING DATA *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * TESTING DATA</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND TESTING DATA</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * THE US CONTACT TRACING RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * THE US CONTACT TRACING RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND THE US CONTACT TRACING RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND THE US CONTACT TRACING RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * THE US CONTACT TRACING RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND THE US CONTACT TRACING RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * THE US CONTACT TRACING RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND THE US CONTACT TRACING RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * HEALTH DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * HEALTH DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND HEALTH DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND HEALTH DEPARTMENTS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * HEALTH DEPARTMENTS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND HEALTH DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * HEALTH DEPARTMENTS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND HEALTH DEPARTMENTS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * CASES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * CASES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND CASES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND CASES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * CASES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND CASES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * CASES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND CASES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * HOMELESS SHELTERS TOOLKIT *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * HOMELESS SHELTERS TOOLKIT *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND HOMELESS SHELTERS TOOLKIT *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND HOMELESS SHELTERS TOOLKIT</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * HOMELESS SHELTERS TOOLKIT</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND HOMELESS SHELTERS TOOLKIT *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * HOMELESS SHELTERS TOOLKIT</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND HOMELESS SHELTERS TOOLKIT</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * STATE PUBLIC HEALTH VETERINARIANS DISASTER SHELTERING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * STATE PUBLIC HEALTH VETERINARIANS DISASTER SHELTERING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND STATE PUBLIC HEALTH VETERINARIANS DISASTER SHELTERING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND STATE PUBLIC HEALTH VETERINARIANS DISASTER SHELTERING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * STATE PUBLIC HEALTH VETERINARIANS DISASTER SHELTERING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND STATE PUBLIC HEALTH VETERINARIANS DISASTER SHELTERING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * STATE PUBLIC HEALTH VETERINARIANS DISASTER SHELTERING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND STATE PUBLIC HEALTH VETERINARIANS DISASTER SHELTERING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * HOUSEHOLD PETS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * HOUSEHOLD PETS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND HOUSEHOLD PETS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND HOUSEHOLD PETS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * HOUSEHOLD PETS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND HOUSEHOLD PETS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * HOUSEHOLD PETS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND HOUSEHOLD PETS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * SERVICE ANIMALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * SERVICE ANIMALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND SERVICE ANIMALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND SERVICE ANIMALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * SERVICE ANIMALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND SERVICE ANIMALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * SERVICE ANIMALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND SERVICE ANIMALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * SUPPORT ANIMALS COMMUNICATION RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * SUPPORT ANIMALS COMMUNICATION RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND SUPPORT ANIMALS COMMUNICATION RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND SUPPORT ANIMALS COMMUNICATION RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * SUPPORT ANIMALS COMMUNICATION RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND SUPPORT ANIMALS COMMUNICATION RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * SUPPORT ANIMALS COMMUNICATION RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND SUPPORT ANIMALS COMMUNICATION RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * HEALTH DEPARTMENTS GUIDANCE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * HEALTH DEPARTMENTS GUIDANCE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND HEALTH DEPARTMENTS GUIDANCE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND HEALTH DEPARTMENTS GUIDANCE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * HEALTH DEPARTMENTS GUIDANCE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND HEALTH DEPARTMENTS GUIDANCE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * HEALTH DEPARTMENTS GUIDANCE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND HEALTH DEPARTMENTS GUIDANCE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * COVID-19 TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * COVID-19 TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND COVID-19 TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND COVID-19 TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * COVID-19 TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND COVID-19 TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * COVID-19 TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND COVID-19 TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * THE COMMUNITY VIRAL TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * THE COMMUNITY VIRAL TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND THE COMMUNITY VIRAL TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND THE COMMUNITY VIRAL TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * THE COMMUNITY VIRAL TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND THE COMMUNITY VIRAL TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * THE COMMUNITY VIRAL TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND THE COMMUNITY VIRAL TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * ANTIBODY TESTING INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * ANTIBODY TESTING INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND ANTIBODY TESTING INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND ANTIBODY TESTING INDIVIDUALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * ANTIBODY TESTING INDIVIDUALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND ANTIBODY TESTING INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * ANTIBODY TESTING INDIVIDUALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND ANTIBODY TESTING INDIVIDUALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * SYMPTOMS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * SYMPTOMS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND SYMPTOMS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND SYMPTOMS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * SYMPTOMS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND SYMPTOMS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * SYMPTOMS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND SYMPTOMS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * RECENT EXPOSURE INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * RECENT EXPOSURE INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND RECENT EXPOSURE INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND RECENT EXPOSURE INDIVIDUALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * RECENT EXPOSURE INDIVIDUALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND RECENT EXPOSURE INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * RECENT EXPOSURE INDIVIDUALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND RECENT EXPOSURE INDIVIDUALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * EXPOSURE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * EXPOSURE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND EXPOSURE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND EXPOSURE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * EXPOSURE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND EXPOSURE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * EXPOSURE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND EXPOSURE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * SPECIAL SETTINGS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * SPECIAL SETTINGS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND SPECIAL SETTINGS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND SPECIAL SETTINGS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * SPECIAL SETTINGS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND SPECIAL SETTINGS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * SPECIAL SETTINGS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND SPECIAL SETTINGS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * BROAD-BASED VIRAL TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * BROAD-BASED VIRAL TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND BROAD-BASED VIRAL TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND BROAD-BASED VIRAL TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * BROAD-BASED VIRAL TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND BROAD-BASED VIRAL TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * BROAD-BASED VIRAL TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND BROAD-BASED VIRAL TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * FACILITIES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * FACILITIES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND FACILITIES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND FACILITIES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * FACILITIES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND FACILITIES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * FACILITIES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND FACILITIES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * KNOWN OR SUSPECTED SARS-COV-2 EXPOSURE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * KNOWN OR SUSPECTED SARS-COV-2 EXPOSURE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND KNOWN OR SUSPECTED SARS-COV-2 EXPOSURE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND KNOWN OR SUSPECTED SARS-COV-2 EXPOSURE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * KNOWN OR SUSPECTED SARS-COV-2 EXPOSURE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND KNOWN OR SUSPECTED SARS-COV-2 EXPOSURE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * KNOWN OR SUSPECTED SARS-COV-2 EXPOSURE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND KNOWN OR SUSPECTED SARS-COV-2 EXPOSURE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * SUBSTANTIAL TRANSMISSION *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * SUBSTANTIAL TRANSMISSION *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND SUBSTANTIAL TRANSMISSION *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND SUBSTANTIAL TRANSMISSION</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * SUBSTANTIAL TRANSMISSION</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND SUBSTANTIAL TRANSMISSION *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * SUBSTANTIAL TRANSMISSION</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND SUBSTANTIAL TRANSMISSION</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * THE COMMUNITY *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * THE COMMUNITY *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND THE COMMUNITY *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND THE COMMUNITY</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * THE COMMUNITY</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND THE COMMUNITY *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * THE COMMUNITY</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND THE COMMUNITY</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * CDC *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * CDC *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP CDC *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP CDC</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * CDC</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP CDC *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * CDC</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP CDC</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * A FORM *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * A FORM *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP A FORM *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP A FORM</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * A FORM</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP A FORM *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * A FORM</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP A FORM</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * A STANDARDIZED APPROACH *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * A STANDARDIZED APPROACH *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP A STANDARDIZED APPROACH *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP A STANDARDIZED APPROACH</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * A STANDARDIZED APPROACH</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP A STANDARDIZED APPROACH *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * A STANDARDIZED APPROACH</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP A STANDARDIZED APPROACH</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * COVID-19 CASES *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * COVID-19 CASES *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP COVID-19 CASES *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP COVID-19 CASES</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * COVID-19 CASES</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP COVID-19 CASES *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * COVID-19 CASES</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP COVID-19 CASES</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * (INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * (INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP (INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP (INDIVIDUALS</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * (INDIVIDUALS</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP (INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * (INDIVIDUALS</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP (INDIVIDUALS</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * AT LEAST ONE RESPIRATORY SPECIMEN *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * AT LEAST ONE RESPIRATORY SPECIMEN *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP AT LEAST ONE RESPIRATORY SPECIMEN *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP AT LEAST ONE RESPIRATORY SPECIMEN</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * AT LEAST ONE RESPIRATORY SPECIMEN</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP AT LEAST ONE RESPIRATORY SPECIMEN *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * AT LEAST ONE RESPIRATORY SPECIMEN</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP AT LEAST ONE RESPIRATORY SPECIMEN</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * THE VIRUS *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * THE VIRUS *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP THE VIRUS *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP THE VIRUS</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * THE VIRUS</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP THE VIRUS *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * THE VIRUS</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP THE VIRUS</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * COVID-19 *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * COVID-19 *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP COVID-19 *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP COVID-19</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * COVID-19</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP COVID-19 *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * COVID-19</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP COVID-19</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * COVID-19 SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * COVID-19 SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW COVID-19 SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW COVID-19 SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * COVID-19 SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW COVID-19 SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * COVID-19 SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW COVID-19 SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * A COMBINATION *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * A COMBINATION *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW A COMBINATION *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW A COMBINATION</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * A COMBINATION</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW A COMBINATION *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * A COMBINATION</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW A COMBINATION</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * DATA SOURCES *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * DATA SOURCES *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW DATA SOURCES *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW DATA SOURCES</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * DATA SOURCES</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW DATA SOURCES *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * DATA SOURCES</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW DATA SOURCES</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * EXISTING INFLUENZA *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * EXISTING INFLUENZA *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW EXISTING INFLUENZA *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW EXISTING INFLUENZA</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * EXISTING INFLUENZA</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW EXISTING INFLUENZA *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * EXISTING INFLUENZA</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW EXISTING INFLUENZA</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * VIRAL RESPIRATORY DISEASE SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * VIRAL RESPIRATORY DISEASE SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW VIRAL RESPIRATORY DISEASE SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW VIRAL RESPIRATORY DISEASE SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * VIRAL RESPIRATORY DISEASE SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW VIRAL RESPIRATORY DISEASE SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * VIRAL RESPIRATORY DISEASE SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW VIRAL RESPIRATORY DISEASE SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * SYNDROMIC SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * SYNDROMIC SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW SYNDROMIC SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW SYNDROMIC SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * SYNDROMIC SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW SYNDROMIC SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * SYNDROMIC SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW SYNDROMIC SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * CASE REPORTING *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * CASE REPORTING *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW CASE REPORTING *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW CASE REPORTING</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * CASE REPORTING</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW CASE REPORTING *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * CASE REPORTING</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW CASE REPORTING</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * COMMERCIAL LAB REPORTING *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * COMMERCIAL LAB REPORTING *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW COMMERCIAL LAB REPORTING *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW COMMERCIAL LAB REPORTING</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * COMMERCIAL LAB REPORTING</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW COMMERCIAL LAB REPORTING *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * COMMERCIAL LAB REPORTING</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW COMMERCIAL LAB REPORTING</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * ONGOING RESEARCH PLATFORMS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * ONGOING RESEARCH PLATFORMS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW ONGOING RESEARCH PLATFORMS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW ONGOING RESEARCH PLATFORMS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * ONGOING RESEARCH PLATFORMS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW ONGOING RESEARCH PLATFORMS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * ONGOING RESEARCH PLATFORMS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW ONGOING RESEARCH PLATFORMS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * OTHER NEW SYSTEMS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * OTHER NEW SYSTEMS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW OTHER NEW SYSTEMS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW OTHER NEW SYSTEMS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * OTHER NEW SYSTEMS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW OTHER NEW SYSTEMS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * OTHER NEW SYSTEMS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW OTHER NEW SYSTEMS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * SPECIFIC QUESTIONS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * SPECIFIC QUESTIONS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW SPECIFIC QUESTIONS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW SPECIFIC QUESTIONS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW * SPECIFIC QUESTIONS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DRAW SPECIFIC QUESTIONS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW * SPECIFIC QUESTIONS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DRAW SPECIFIC QUESTIONS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * OTHER NEW SYSTEMS *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * OTHER NEW SYSTEMS *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE OTHER NEW SYSTEMS *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE OTHER NEW SYSTEMS</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * OTHER NEW SYSTEMS</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE OTHER NEW SYSTEMS *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * OTHER NEW SYSTEMS</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE OTHER NEW SYSTEMS</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * SPECIFIC QUESTIONS *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * SPECIFIC QUESTIONS *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE SPECIFIC QUESTIONS *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE SPECIFIC QUESTIONS</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * SPECIFIC QUESTIONS</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE SPECIFIC QUESTIONS *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * SPECIFIC QUESTIONS</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE SPECIFIC QUESTIONS</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * AN UPDATED, ACCURATE PICTURE *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * AN UPDATED, ACCURATE PICTURE *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE AN UPDATED, ACCURATE PICTURE *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE AN UPDATED, ACCURATE PICTURE</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * AN UPDATED, ACCURATE PICTURE</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE AN UPDATED, ACCURATE PICTURE *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * AN UPDATED, ACCURATE PICTURE</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE AN UPDATED, ACCURATE PICTURE</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * SARS-COV-2 SPREAD *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * SARS-COV-2 SPREAD *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE SARS-COV-2 SPREAD *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE SARS-COV-2 SPREAD</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * SARS-COV-2 SPREAD</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE SARS-COV-2 SPREAD *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * SARS-COV-2 SPREAD</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE SARS-COV-2 SPREAD</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * ITS EFFECTS *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * ITS EFFECTS *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE ITS EFFECTS *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE ITS EFFECTS</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * ITS EFFECTS</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE ITS EFFECTS *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * ITS EFFECTS</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE ITS EFFECTS</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE THE UNITED STATES</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * THE UNITED STATES</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * THE UNITED STATES</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE THE UNITED STATES</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * DATA *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * DATA *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE DATA *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE DATA</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * DATA</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE DATA *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * DATA</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE DATA</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * THE U. S. NATIONAL PUBLIC HEALTH RESPONSE *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * THE U. S. NATIONAL PUBLIC HEALTH RESPONSE *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE THE U. S. NATIONAL PUBLIC HEALTH RESPONSE *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE THE U. S. NATIONAL PUBLIC HEALTH RESPONSE</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * THE U. S. NATIONAL PUBLIC HEALTH RESPONSE</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE THE U. S. NATIONAL PUBLIC HEALTH RESPONSE *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * THE U. S. NATIONAL PUBLIC HEALTH RESPONSE</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE THE U. S. NATIONAL PUBLIC HEALTH RESPONSE</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * COVID-19 *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * COVID-19 *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE COVID-19 *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE COVID-19</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE * COVID-19</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CREATE COVID-19 *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE * COVID-19</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CREATE COVID-19</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE SURVEILLANCE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * SURVEILLANCE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * SURVEILLANCE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE SURVEILLANCE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * COVID-19 AND COVID-19 CAUSE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * COVID-19 AND COVID-19 CAUSE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE COVID-19 AND COVID-19 CAUSE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE COVID-19 AND COVID-19 CAUSE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * COVID-19 AND COVID-19 CAUSE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE COVID-19 AND COVID-19 CAUSE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * COVID-19 AND COVID-19 CAUSE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE COVID-19 AND COVID-19 CAUSE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * SARS-COV-2 *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * SARS-COV-2 *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE SARS-COV-2 *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE SARS-COV-2</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * SARS-COV-2</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE SARS-COV-2 *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * SARS-COV-2</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE SARS-COV-2</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE THE UNITED STATES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * THE UNITED STATES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * THE UNITED STATES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE THE UNITED STATES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * CDC *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * CDC *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE CDC *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE CDC</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * CDC</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE CDC *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * CDC</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE CDC</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * MULTIPLE SURVEILLANCE SYSTEMS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * MULTIPLE SURVEILLANCE SYSTEMS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE MULTIPLE SURVEILLANCE SYSTEMS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE MULTIPLE SURVEILLANCE SYSTEMS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * MULTIPLE SURVEILLANCE SYSTEMS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE MULTIPLE SURVEILLANCE SYSTEMS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * MULTIPLE SURVEILLANCE SYSTEMS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE MULTIPLE SURVEILLANCE SYSTEMS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * COLLABORATION *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * COLLABORATION *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE COLLABORATION *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE COLLABORATION</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * COLLABORATION</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE COLLABORATION *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * COLLABORATION</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE COLLABORATION</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * STATE, LOCAL AND TERRITORIAL HEALTH DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * STATE, LOCAL AND TERRITORIAL HEALTH DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE STATE, LOCAL AND TERRITORIAL HEALTH DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE STATE, LOCAL AND TERRITORIAL HEALTH DEPARTMENTS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * STATE, LOCAL AND TERRITORIAL HEALTH DEPARTMENTS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE STATE, LOCAL AND TERRITORIAL HEALTH DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * STATE, LOCAL AND TERRITORIAL HEALTH DEPARTMENTS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE STATE, LOCAL AND TERRITORIAL HEALTH DEPARTMENTS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * PUBLIC HEALTH *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * PUBLIC HEALTH *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE PUBLIC HEALTH *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE PUBLIC HEALTH</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * PUBLIC HEALTH</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE PUBLIC HEALTH *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * PUBLIC HEALTH</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE PUBLIC HEALTH</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * COMMERCIAL AND CLINICAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * COMMERCIAL AND CLINICAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE COMMERCIAL AND CLINICAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE COMMERCIAL AND CLINICAL LABORATORIES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * COMMERCIAL AND CLINICAL LABORATORIES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE COMMERCIAL AND CLINICAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * COMMERCIAL AND CLINICAL LABORATORIES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE COMMERCIAL AND CLINICAL LABORATORIES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * VITAL STATISTICS OFFICES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * VITAL STATISTICS OFFICES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE VITAL STATISTICS OFFICES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE VITAL STATISTICS OFFICES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * VITAL STATISTICS OFFICES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE VITAL STATISTICS OFFICES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * VITAL STATISTICS OFFICES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE VITAL STATISTICS OFFICES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * HEALTH CARE PROVIDERS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * HEALTH CARE PROVIDERS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE HEALTH CARE PROVIDERS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE HEALTH CARE PROVIDERS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * HEALTH CARE PROVIDERS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE HEALTH CARE PROVIDERS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * HEALTH CARE PROVIDERS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE HEALTH CARE PROVIDERS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * EMERGENCY DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * EMERGENCY DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE EMERGENCY DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE EMERGENCY DEPARTMENTS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * EMERGENCY DEPARTMENTS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE EMERGENCY DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * EMERGENCY DEPARTMENTS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE EMERGENCY DEPARTMENTS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * ACADEMIC PARTNERS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * ACADEMIC PARTNERS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE ACADEMIC PARTNERS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE ACADEMIC PARTNERS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * ACADEMIC PARTNERS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE ACADEMIC PARTNERS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * ACADEMIC PARTNERS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE ACADEMIC PARTNERS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * COVID-19 DISEASE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * COVID-19 DISEASE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE COVID-19 DISEASE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE COVID-19 DISEASE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * COVID-19 DISEASE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE COVID-19 DISEASE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * COVID-19 DISEASE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE COVID-19 DISEASE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * THE UNITED SCDCES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * THE UNITED SCDCES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE THE UNITED SCDCES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE THE UNITED SCDCES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE * THE UNITED SCDCES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USE THE UNITED SCDCES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE * THE UNITED SCDCES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USE THE UNITED SCDCES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * CDC *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * CDC *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE CDC *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE CDC</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * CDC</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE CDC *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * CDC</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE CDC</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * A WEEKLY SUMMARY *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * A WEEKLY SUMMARY *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE A WEEKLY SUMMARY *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE A WEEKLY SUMMARY</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * A WEEKLY SUMMARY</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE A WEEKLY SUMMARY *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * A WEEKLY SUMMARY</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE A WEEKLY SUMMARY</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * INTERPRETATION *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * INTERPRETATION *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE INTERPRETATION *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE INTERPRETATION</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * INTERPRETATION</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE INTERPRETATION *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * INTERPRETATION</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE INTERPRETATION</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * KEY INDICATORS *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * KEY INDICATORS *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE KEY INDICATORS *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE KEY INDICATORS</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * KEY INDICATORS</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE KEY INDICATORS *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * KEY INDICATORS</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE KEY INDICATORS</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THE COVID-19 PANDEMIC *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THE COVID-19 PANDEMIC *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THE COVID-19 PANDEMIC *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THE COVID-19 PANDEMIC</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THE COVID-19 PANDEMIC</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THE COVID-19 PANDEMIC *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THE COVID-19 PANDEMIC</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THE COVID-19 PANDEMIC</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THE UNITED STATES</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THE UNITED STATES</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THE UNITED STATES</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THE UNITED STATES</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR * CDC *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR * CDC *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR CDC *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR CDC</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR * CDC</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR CDC *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR * CDC</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR CDC</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR * LAB-CONFIRMED COVID-19 HOSPITALIZATIONS *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR * LAB-CONFIRMED COVID-19 HOSPITALIZATIONS *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR LAB-CONFIRMED COVID-19 HOSPITALIZATIONS *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR LAB-CONFIRMED COVID-19 HOSPITALIZATIONS</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR * LAB-CONFIRMED COVID-19 HOSPITALIZATIONS</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR LAB-CONFIRMED COVID-19 HOSPITALIZATIONS *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR * LAB-CONFIRMED COVID-19 HOSPITALIZATIONS</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR LAB-CONFIRMED COVID-19 HOSPITALIZATIONS</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR * RISK FACTORS *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR * RISK FACTORS *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR RISK FACTORS *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR RISK FACTORS</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR * RISK FACTORS</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR RISK FACTORS *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR * RISK FACTORS</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR RISK FACTORS</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR * OUTCOMES *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR * OUTCOMES *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR OUTCOMES *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR OUTCOMES</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR * OUTCOMES</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MONITOR OUTCOMES *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR * OUTCOMES</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MONITOR OUTCOMES</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PROVISIONAL DEATH COUNTS *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PROVISIONAL DEATH COUNTS *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PROVISIONAL DEATH COUNTS *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PROVISIONAL DEATH COUNTS</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PROVISIONAL DEATH COUNTS</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PROVISIONAL DEATH COUNTS *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PROVISIONAL DEATH COUNTS</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PROVISIONAL DEATH COUNTS</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * COVID-19 *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * COVID-19 *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE COVID-19 *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE COVID-19</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * COVID-19</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE COVID-19 *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * COVID-19</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE COVID-19</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PNEUMONIA *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PNEUMONIA *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PNEUMONIA *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PNEUMONIA</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PNEUMONIA</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PNEUMONIA *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PNEUMONIA</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PNEUMONIA</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * DEATH CERTIFICATES *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * DEATH CERTIFICATES *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE DEATH CERTIFICATES *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE DEATH CERTIFICATES</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * DEATH CERTIFICATES</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE DEATH CERTIFICATES *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * DEATH CERTIFICATES</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE DEATH CERTIFICATES</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * UPDATES *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * UPDATES *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE UPDATES *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE UPDATES</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * UPDATES</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE UPDATES *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * UPDATES</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE UPDATES</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * FURTHER SPREAD *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * FURTHER SPREAD *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP FURTHER SPREAD *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP FURTHER SPREAD</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * FURTHER SPREAD</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP FURTHER SPREAD *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * FURTHER SPREAD</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP FURTHER SPREAD</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * INFORMATION *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * INFORMATION *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP INFORMATION *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP INFORMATION</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * INFORMATION</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP INFORMATION *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * INFORMATION</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP INFORMATION</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * SARS-COV-2 IMPACT *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * SARS-COV-2 IMPACT *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP SARS-COV-2 IMPACT *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP SARS-COV-2 IMPACT</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * SARS-COV-2 IMPACT</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP SARS-COV-2 IMPACT *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * SARS-COV-2 IMPACT</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP SARS-COV-2 IMPACT</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * HEALTH OUTCOMES *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * HEALTH OUTCOMES *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP HEALTH OUTCOMES *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP HEALTH OUTCOMES</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * HEALTH OUTCOMES</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP HEALTH OUTCOMES *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * HEALTH OUTCOMES</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP HEALTH OUTCOMES</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * THE COVID-19 DATA INTEROPERABILITY STANDARDS *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * THE COVID-19 DATA INTEROPERABILITY STANDARDS *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP THE COVID-19 DATA INTEROPERABILITY STANDARDS *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP THE COVID-19 DATA INTEROPERABILITY STANDARDS</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * THE COVID-19 DATA INTEROPERABILITY STANDARDS</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP THE COVID-19 DATA INTEROPERABILITY STANDARDS *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * THE COVID-19 DATA INTEROPERABILITY STANDARDS</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP THE COVID-19 DATA INTEROPERABILITY STANDARDS</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * REGULATIONS REPOSITORY *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * REGULATIONS REPOSITORY *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP REGULATIONS REPOSITORY *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP REGULATIONS REPOSITORY</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * REGULATIONS REPOSITORY</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP REGULATIONS REPOSITORY *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * REGULATIONS REPOSITORY</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP REGULATIONS REPOSITORY</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * COMMUNICATION *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * COMMUNICATION *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP COMMUNICATION *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP COMMUNICATION</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * COMMUNICATION</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP COMMUNICATION *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * COMMUNICATION</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP COMMUNICATION</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * COLLABORATION *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * COLLABORATION *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP COLLABORATION *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP COLLABORATION</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * COLLABORATION</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP COLLABORATION *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * COLLABORATION</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP COLLABORATION</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * STANDARD DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * STANDARD DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP STANDARD DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP STANDARD DEVELOPMENT</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * STANDARD DEVELOPMENT</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP STANDARD DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * STANDARD DEVELOPMENT</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP STANDARD DEVELOPMENT</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * STANDARD IMPLEMENTATION ORGANIZATIONS *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * STANDARD IMPLEMENTATION ORGANIZATIONS *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP STANDARD IMPLEMENTATION ORGANIZATIONS *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP STANDARD IMPLEMENTATION ORGANIZATIONS</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * STANDARD IMPLEMENTATION ORGANIZATIONS</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP STANDARD IMPLEMENTATION ORGANIZATIONS *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * STANDARD IMPLEMENTATION ORGANIZATIONS</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP STANDARD IMPLEMENTATION ORGANIZATIONS</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * CDC *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * CDC *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK CDC *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK CDC</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * CDC</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK CDC *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * CDC</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK CDC</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * STATE AND TERRITORIAL PUBLIC HEALTH PARTNERS *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * STATE AND TERRITORIAL PUBLIC HEALTH PARTNERS *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK STATE AND TERRITORIAL PUBLIC HEALTH PARTNERS *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK STATE AND TERRITORIAL PUBLIC HEALTH PARTNERS</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * STATE AND TERRITORIAL PUBLIC HEALTH PARTNERS</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK STATE AND TERRITORIAL PUBLIC HEALTH PARTNERS *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * STATE AND TERRITORIAL PUBLIC HEALTH PARTNERS</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK STATE AND TERRITORIAL PUBLIC HEALTH PARTNERS</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * COVID-19 CASE *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * COVID-19 CASE *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK COVID-19 CASE *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK COVID-19 CASE</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * COVID-19 CASE</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK COVID-19 CASE *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * COVID-19 CASE</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK COVID-19 CASE</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * THE COVID-19 CASE DEFINITION *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * THE COVID-19 CASE DEFINITION *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE THE COVID-19 CASE DEFINITION *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE THE COVID-19 CASE DEFINITION</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * THE COVID-19 CASE DEFINITION</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE THE COVID-19 CASE DEFINITION *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * THE COVID-19 CASE DEFINITION</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE THE COVID-19 CASE DEFINITION</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * THE COUNCIL *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * THE COUNCIL *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE THE COUNCIL *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE THE COUNCIL</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * THE COUNCIL</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE THE COUNCIL *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * THE COUNCIL</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE THE COUNCIL</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * STATE AND TERRITORIAL EPIDEMIOLOGISTS *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * STATE AND TERRITORIAL EPIDEMIOLOGISTS *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE STATE AND TERRITORIAL EPIDEMIOLOGISTS *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE STATE AND TERRITORIAL EPIDEMIOLOGISTS</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * STATE AND TERRITORIAL EPIDEMIOLOGISTS</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE STATE AND TERRITORIAL EPIDEMIOLOGISTS *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * STATE AND TERRITORIAL EPIDEMIOLOGISTS</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE STATE AND TERRITORIAL EPIDEMIOLOGISTS</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * CSTE *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * CSTE *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE CSTE *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE CSTE</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * CSTE</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE CSTE *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * CSTE</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE CSTE</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * APRIL *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * APRIL *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE APRIL *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE APRIL</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * APRIL</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE APRIL *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * APRIL</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE APRIL</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * AN INTERIM COVID-19 POSITION STATEMENT *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * AN INTERIM COVID-19 POSITION STATEMENT *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE AN INTERIM COVID-19 POSITION STATEMENT *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE AN INTERIM COVID-19 POSITION STATEMENT</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * AN INTERIM COVID-19 POSITION STATEMENT</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE AN INTERIM COVID-19 POSITION STATEMENT *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * AN INTERIM COVID-19 POSITION STATEMENT</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE AN INTERIM COVID-19 POSITION STATEMENT</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * A CASE DEFINITION *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * A CASE DEFINITION *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE A CASE DEFINITION *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE A CASE DEFINITION</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * A CASE DEFINITION</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE A CASE DEFINITION *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * A CASE DEFINITION</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE A CASE DEFINITION</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * COVID-19 *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * COVID-19 *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE COVID-19 *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE COVID-19</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE * COVID-19</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDIZE COVID-19 *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE * COVID-19</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDIZE COVID-19</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * ITS IMPACT *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * ITS IMPACT *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP ITS IMPACT *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP ITS IMPACT</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP * ITS IMPACT</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOP ITS IMPACT *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP * ITS IMPACT</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOP ITS IMPACT</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE * CASE-BASED SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE * CASE-BASED SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE CASE-BASED SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE CASE-BASED SURVEILLANCE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE * CASE-BASED SURVEILLANCE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE CASE-BASED SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE * CASE-BASED SURVEILLANCE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE CASE-BASED SURVEILLANCE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE * MECHANISMS *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE * MECHANISMS *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE MECHANISMS *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE MECHANISMS</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE * MECHANISMS</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE MECHANISMS *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE * MECHANISMS</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE MECHANISMS</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE * CASE DATA *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE * CASE DATA *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE CASE DATA *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE CASE DATA</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE * CASE DATA</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE CASE DATA *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE * CASE DATA</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE CASE DATA</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE * SHARE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE * SHARE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE SHARE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE SHARE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE * SHARE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE SHARE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE * SHARE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE SHARE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE * CDC PARTNERS *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE * CDC PARTNERS *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE CDC PARTNERS *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE CDC PARTNERS</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE * CDC PARTNERS</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE CDC PARTNERS *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE * CDC PARTNERS</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE CDC PARTNERS</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE * TECHNICAL ASSISTANCE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE * TECHNICAL ASSISTANCE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE TECHNICAL ASSISTANCE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE TECHNICAL ASSISTANCE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE * TECHNICAL ASSISTANCE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE TECHNICAL ASSISTANCE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE * TECHNICAL ASSISTANCE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE TECHNICAL ASSISTANCE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE * NEW HL7 MESSAGE MAPPING GUIDES *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE * NEW HL7 MESSAGE MAPPING GUIDES *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE NEW HL7 MESSAGE MAPPING GUIDES *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE NEW HL7 MESSAGE MAPPING GUIDES</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE * NEW HL7 MESSAGE MAPPING GUIDES</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE NEW HL7 MESSAGE MAPPING GUIDES *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE * NEW HL7 MESSAGE MAPPING GUIDES</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE NEW HL7 MESSAGE MAPPING GUIDES</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * NATIONAL SYNDROMIC SURVEILLANCE PROGRAM *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * NATIONAL SYNDROMIC SURVEILLANCE PROGRAM *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE NATIONAL SYNDROMIC SURVEILLANCE PROGRAM *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE NATIONAL SYNDROMIC SURVEILLANCE PROGRAM</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * NATIONAL SYNDROMIC SURVEILLANCE PROGRAM</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE NATIONAL SYNDROMIC SURVEILLANCE PROGRAM *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * NATIONAL SYNDROMIC SURVEILLANCE PROGRAM</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE NATIONAL SYNDROMIC SURVEILLANCE PROGRAM</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * NSSP *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * NSSP *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE NSSP *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE NSSP</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * NSSP</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE NSSP *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * NSSP</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE NSSP</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * ONBOARDED FACILITIES *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * ONBOARDED FACILITIES *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE ONBOARDED FACILITIES *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE ONBOARDED FACILITIES</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * ONBOARDED FACILITIES</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE ONBOARDED FACILITIES *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * ONBOARDED FACILITIES</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE ONBOARDED FACILITIES</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * COVID-19 TEST ORDERS *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * COVID-19 TEST ORDERS *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE COVID-19 TEST ORDERS *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE COVID-19 TEST ORDERS</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * COVID-19 TEST ORDERS</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE COVID-19 TEST ORDERS *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * COVID-19 TEST ORDERS</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE COVID-19 TEST ORDERS</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * RESULTS *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * RESULTS *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE RESULTS *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE RESULTS</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * RESULTS</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE RESULTS *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * RESULTS</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE RESULTS</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * 6 MAJOR COMMERCIAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * 6 MAJOR COMMERCIAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE 6 MAJOR COMMERCIAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE 6 MAJOR COMMERCIAL LABORATORIES</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * 6 MAJOR COMMERCIAL LABORATORIES</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE 6 MAJOR COMMERCIAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * 6 MAJOR COMMERCIAL LABORATORIES</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE 6 MAJOR COMMERCIAL LABORATORIES</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * QUALITY-CONTROLLED LINE-LEVEL DATA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * QUALITY-CONTROLLED LINE-LEVEL DATA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE QUALITY-CONTROLLED LINE-LEVEL DATA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE QUALITY-CONTROLLED LINE-LEVEL DATA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * QUALITY-CONTROLLED LINE-LEVEL DATA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE QUALITY-CONTROLLED LINE-LEVEL DATA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * QUALITY-CONTROLLED LINE-LEVEL DATA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE QUALITY-CONTROLLED LINE-LEVEL DATA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * ED VISITS *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * ED VISITS *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE ED VISITS *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE ED VISITS</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * ED VISITS</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE ED VISITS *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * ED VISITS</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE ED VISITS</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * COVID-19—INCLUDING PCR *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * COVID-19—INCLUDING PCR *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE COVID-19—INCLUDING PCR *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE COVID-19—INCLUDING PCR</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * COVID-19—INCLUDING PCR</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE COVID-19—INCLUDING PCR *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * COVID-19—INCLUDING PCR</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE COVID-19—INCLUDING PCR</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * NOW IGA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * NOW IGA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE NOW IGA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE NOW IGA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * NOW IGA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE NOW IGA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * NOW IGA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE NOW IGA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * IGG *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * IGG *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE IGG *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE IGG</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * IGG</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE IGG *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * IGG</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE IGG</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * IGM *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * IGM *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE IGM *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE IGM</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * IGM</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE IGM *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * IGM</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE IGM</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * ESSENCE *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * ESSENCE *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE ESSENCE *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE ESSENCE</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * ESSENCE</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE ESSENCE *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * ESSENCE</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE ESSENCE</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * ADVANCED TOOLS *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * ADVANCED TOOLS *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE ADVANCED TOOLS *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE ADVANCED TOOLS</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * ADVANCED TOOLS</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE ADVANCED TOOLS *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * ADVANCED TOOLS</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE ADVANCED TOOLS</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THESE DATA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THESE DATA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THESE DATA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THESE DATA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THESE DATA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THESE DATA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THESE DATA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THESE DATA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * INSIGHTS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * INSIGHTS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT INSIGHTS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT INSIGHTS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * INSIGHTS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT INSIGHTS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * INSIGHTS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT INSIGHTS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * WHAT *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * WHAT *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT WHAT *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT WHAT</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * WHAT</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT WHAT *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * WHAT</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT WHAT</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * RESPONSE *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * RESPONSE *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT RESPONSE *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT RESPONSE</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * RESPONSE</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT RESPONSE *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * RESPONSE</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT RESPONSE</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * POLICIES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * POLICIES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT POLICIES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT POLICIES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * POLICIES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT POLICIES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * POLICIES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT POLICIES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * COVID-19 *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * COVID-19 *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT COVID-19 *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT COVID-19</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * COVID-19</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT COVID-19 *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * COVID-19</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT COVID-19</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE * EMAIL UPDATES *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE * EMAIL UPDATES *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE EMAIL UPDATES *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE EMAIL UPDATES</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE * EMAIL UPDATES</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE EMAIL UPDATES *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE * EMAIL UPDATES</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE EMAIL UPDATES</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE * YOUR EMAIL ADDRESS *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE * YOUR EMAIL ADDRESS *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE YOUR EMAIL ADDRESS *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE YOUR EMAIL ADDRESS</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE * YOUR EMAIL ADDRESS</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE YOUR EMAIL ADDRESS *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE * YOUR EMAIL ADDRESS</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE YOUR EMAIL ADDRESS</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE * LINKS *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE * LINKS *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE LINKS *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE LINKS</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE * LINKS</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE LINKS *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE * LINKS</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE LINKS</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE * THIS ICON *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE * THIS ICON *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE THIS ICON *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE THIS ICON</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE * THIS ICON</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE THIS ICON *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE * THIS ICON</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE THIS ICON</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE * YOU *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE * YOU *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE YOU *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE YOU</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE * YOU</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE YOU *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE * YOU</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE YOU</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE * THE CDC WEBSITE *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE * THE CDC WEBSITE *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE THE CDC WEBSITE *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE THE CDC WEBSITE</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE * THE CDC WEBSITE</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INDICATE THE CDC WEBSITE *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE * THE CDC WEBSITE</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INDICATE THE CDC WEBSITE</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * LABORATORIES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * LABORATORIES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND LABORATORIES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND LABORATORIES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND * LABORATORIES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FIND LABORATORIES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND * LABORATORIES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FIND LABORATORIES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * THE DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * THE DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK THE DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK THE DEPARTMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * THE DEPARTMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK THE DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * THE DEPARTMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK THE DEPARTMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * HEALTH *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * HEALTH *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK HEALTH *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK HEALTH</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * HEALTH</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK HEALTH *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * HEALTH</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK HEALTH</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * HUMAN SERVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * HUMAN SERVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK HUMAN SERVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK HUMAN SERVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * HUMAN SERVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK HUMAN SERVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * HUMAN SERVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK HUMAN SERVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * HHS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * HHS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK HHS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK HHS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * HHS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK HHS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * HHS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK HHS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * THE U. S. GOVERNMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * THE U. S. GOVERNMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK THE U. S. GOVERNMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK THE U. S. GOVERNMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * THE U. S. GOVERNMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK THE U. S. GOVERNMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * THE U. S. GOVERNMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK THE U. S. GOVERNMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * THE DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * THE DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK THE DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK THE DEPARTMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * THE DEPARTMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK THE DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * THE DEPARTMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK THE DEPARTMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * DEFENSE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * DEFENSE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK DEFENSE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK DEFENSE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * DEFENSE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK DEFENSE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * DEFENSE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK DEFENSE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * POTENTIAL PRODUCTS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * POTENTIAL PRODUCTS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK POTENTIAL PRODUCTS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK POTENTIAL PRODUCTS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * POTENTIAL PRODUCTS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK POTENTIAL PRODUCTS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * POTENTIAL PRODUCTS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK POTENTIAL PRODUCTS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * PUBLIC AND PRIVATE SECTORS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * PUBLIC AND PRIVATE SECTORS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK PUBLIC AND PRIVATE SECTORS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK PUBLIC AND PRIVATE SECTORS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * PUBLIC AND PRIVATE SECTORS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK PUBLIC AND PRIVATE SECTORS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * PUBLIC AND PRIVATE SECTORS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK PUBLIC AND PRIVATE SECTORS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * PROMISING CANDIDATES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * PROMISING CANDIDATES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK PROMISING CANDIDATES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK PROMISING CANDIDATES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * PROMISING CANDIDATES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK PROMISING CANDIDATES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * PROMISING CANDIDATES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK PROMISING CANDIDATES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK DEVELOPMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * DEVELOPMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * DEVELOPMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK DEVELOPMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * LICENSURE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * LICENSURE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK LICENSURE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK LICENSURE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK * LICENSURE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORK LICENSURE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK * LICENSURE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORK LICENSURE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THE DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THE DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THE DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THE DEPARTMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THE DEPARTMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THE DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THE DEPARTMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THE DEPARTMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * HEALTH *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * HEALTH *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE HEALTH *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE HEALTH</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * HEALTH</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE HEALTH *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * HEALTH</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE HEALTH</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * HUMAN SERVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * HUMAN SERVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE HUMAN SERVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE HUMAN SERVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * HUMAN SERVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE HUMAN SERVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * HUMAN SERVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE HUMAN SERVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * HHS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * HHS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE HHS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE HHS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * HHS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE HHS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * HHS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE HHS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * CARE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * CARE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE CARE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE CARE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * CARE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE CARE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * CARE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE CARE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * DEVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * DEVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE DEVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE DEVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * DEVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE DEVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * DEVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE DEVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PUBLIC HEALTH LABS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PUBLIC HEALTH LABS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PUBLIC HEALTH LABS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PUBLIC HEALTH LABS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PUBLIC HEALTH LABS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PUBLIC HEALTH LABS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PUBLIC HEALTH LABS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PUBLIC HEALTH LABS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PHLS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PHLS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PHLS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PHLS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PHLS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PHLS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PHLS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PHLS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * EVERY STATE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * EVERY STATE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE EVERY STATE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE EVERY STATE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * EVERY STATE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE EVERY STATE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * EVERY STATE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE EVERY STATE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * TERRITORY *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * TERRITORY *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE TERRITORY *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE TERRITORY</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * TERRITORY</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE TERRITORY *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * TERRITORY</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE TERRITORY</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * D. C. FDA *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * D. C. FDA *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE D. C. FDA *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE D. C. FDA</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * D. C. FDA</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE D. C. FDA *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * D. C. FDA</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE D. C. FDA</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * EMERGENCY USE AUTHORIZATIONS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * EMERGENCY USE AUTHORIZATIONS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE EMERGENCY USE AUTHORIZATIONS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE EMERGENCY USE AUTHORIZATIONS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * EMERGENCY USE AUTHORIZATIONS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE EMERGENCY USE AUTHORIZATIONS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * EMERGENCY USE AUTHORIZATIONS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE EMERGENCY USE AUTHORIZATIONS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * COVID-19 TESTS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * COVID-19 TESTS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE COVID-19 TESTS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE COVID-19 TESTS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * COVID-19 TESTS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE COVID-19 TESTS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * COVID-19 TESTS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE COVID-19 TESTS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE * D. C. D. C. FDA *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE * D. C. D. C. FDA *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE D. C. D. C. FDA *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE D. C. D. C. FDA</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE * D. C. D. C. FDA</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE D. C. D. C. FDA *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE * D. C. D. C. FDA</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE D. C. D. C. FDA</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE * SEVERAL EMERGENCY USE AUTHORIZATIONS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE * SEVERAL EMERGENCY USE AUTHORIZATIONS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE SEVERAL EMERGENCY USE AUTHORIZATIONS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE SEVERAL EMERGENCY USE AUTHORIZATIONS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE * SEVERAL EMERGENCY USE AUTHORIZATIONS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE SEVERAL EMERGENCY USE AUTHORIZATIONS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE * SEVERAL EMERGENCY USE AUTHORIZATIONS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE SEVERAL EMERGENCY USE AUTHORIZATIONS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE * EUAS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE * EUAS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE EUAS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE EUAS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE * EUAS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE EUAS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE * EUAS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE EUAS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE * THE USE *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE * THE USE *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE THE USE *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE THE USE</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE * THE USE</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE THE USE *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE * THE USE</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE THE USE</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE * NEW VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE * NEW VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE NEW VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE NEW VIRAL TESTS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE * NEW VIRAL TESTS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE NEW VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE * NEW VIRAL TESTS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE NEW VIRAL TESTS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE * THE SARS-COV-2 VIRUS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE * THE SARS-COV-2 VIRUS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE THE SARS-COV-2 VIRUS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE THE SARS-COV-2 VIRUS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE * THE SARS-COV-2 VIRUS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE THE SARS-COV-2 VIRUS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE * THE SARS-COV-2 VIRUS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE THE SARS-COV-2 VIRUS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE * COVID-19 *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE * COVID-19 *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE COVID-19 *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE COVID-19</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE * COVID-19</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ISSUE COVID-19 *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE * COVID-19</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ISSUE COVID-19</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * PUBLIC HEALTH EMERGENCIES *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * PUBLIC HEALTH EMERGENCIES *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE PUBLIC HEALTH EMERGENCIES *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE PUBLIC HEALTH EMERGENCIES</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * PUBLIC HEALTH EMERGENCIES</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE PUBLIC HEALTH EMERGENCIES *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * PUBLIC HEALTH EMERGENCIES</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE PUBLIC HEALTH EMERGENCIES</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * SECTION *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * SECTION *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE SECTION *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE SECTION</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * SECTION</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE SECTION *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * SECTION</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE SECTION</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE FD&amp;C ACT *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE FD&amp;C ACT *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE FD&amp;C ACT *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE FD&amp;C ACT</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE FD&amp;C ACT</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE FD&amp;C ACT *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE FD&amp;C ACT</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE FD&amp;C ACT</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * D. C. D. C. FDA *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * D. C. D. C. FDA *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE D. C. D. C. FDA *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE D. C. D. C. FDA</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * D. C. D. C. FDA</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE D. C. D. C. FDA *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * D. C. D. C. FDA</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE D. C. D. C. FDA</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * CERTAIN CRITERIA *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * CERTAIN CRITERIA *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE CERTAIN CRITERIA *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE CERTAIN CRITERIA</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * CERTAIN CRITERIA</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE CERTAIN CRITERIA *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * CERTAIN CRITERIA</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE CERTAIN CRITERIA</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE USE *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE USE *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE USE *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE USE</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE USE</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE USE *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE USE</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE USE</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * DISTRIBUTION *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * DISTRIBUTION *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE DISTRIBUTION *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE DISTRIBUTION</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * DISTRIBUTION</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE DISTRIBUTION *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * DISTRIBUTION</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE DISTRIBUTION</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * POTENTIALLY LIFE-SAVING MEDICAL PRODUCTS *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * POTENTIALLY LIFE-SAVING MEDICAL PRODUCTS *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE POTENTIALLY LIFE-SAVING MEDICAL PRODUCTS *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE POTENTIALLY LIFE-SAVING MEDICAL PRODUCTS</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * POTENTIALLY LIFE-SAVING MEDICAL PRODUCTS</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE POTENTIALLY LIFE-SAVING MEDICAL PRODUCTS *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * POTENTIALLY LIFE-SAVING MEDICAL PRODUCTS</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE POTENTIALLY LIFE-SAVING MEDICAL PRODUCTS</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE DISEASE *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE DISEASE *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE DISEASE *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE DISEASE</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE DISEASE</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE DISEASE *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE DISEASE</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE DISEASE</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE VIRAL TESTS</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * VIRAL TESTS</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * VIRAL TESTS</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE VIRAL TESTS</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * RESOURCES *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * RESOURCES *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE RESOURCES *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE RESOURCES</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * RESOURCES</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE RESOURCES *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * RESOURCES</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE RESOURCES</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * LABORATORIES *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * LABORATORIES *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE LABORATORIES *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE LABORATORIES</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * LABORATORIES</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE LABORATORIES *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * LABORATORIES</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE LABORATORIES</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * INTERIM GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * INTERIM GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE INTERIM GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE INTERIM GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * INTERIM GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE INTERIM GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * INTERIM GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE INTERIM GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * LABORATORY PROFESSIONALS *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * LABORATORY PROFESSIONALS *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE LABORATORY PROFESSIONALS *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE LABORATORY PROFESSIONALS</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * LABORATORY PROFESSIONALS</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE LABORATORY PROFESSIONALS *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * LABORATORY PROFESSIONALS</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE LABORATORY PROFESSIONALS</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * SPECIMENS *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * SPECIMENS *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE SPECIMENS *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE SPECIMENS</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * SPECIMENS</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE SPECIMENS *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * SPECIMENS</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE SPECIMENS</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PERSONS *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PERSONS *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PERSONS *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PERSONS</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PERSONS</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PERSONS *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PERSONS</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PERSONS</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * INVESTIGATION *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * INVESTIGATION *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE INVESTIGATION *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE INVESTIGATION</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * INVESTIGATION</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE INVESTIGATION *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * INVESTIGATION</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE INVESTIGATION</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PUI *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PUI *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PUI *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PUI</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PUI</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PUI *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PUI</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PUI</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * ORDER *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * ORDER *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE ORDER *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE ORDER</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * ORDER</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE ORDER *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * ORDER</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE ORDER</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * HEALTH CARE WORKERS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * HEALTH CARE WORKERS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE HEALTH CARE WORKERS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE HEALTH CARE WORKERS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * HEALTH CARE WORKERS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE HEALTH CARE WORKERS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * HEALTH CARE WORKERS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE HEALTH CARE WORKERS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * LABORATORIANS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * LABORATORIANS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE LABORATORIANS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE LABORATORIANS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * LABORATORIANS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE LABORATORIANS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * LABORATORIANS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE LABORATORIANS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * LABORATORY BIOSAFETY GUIDELINES *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * LABORATORY BIOSAFETY GUIDELINES *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE LABORATORY BIOSAFETY GUIDELINES *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE LABORATORY BIOSAFETY GUIDELINES</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * LABORATORY BIOSAFETY GUIDELINES</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE LABORATORY BIOSAFETY GUIDELINES *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * LABORATORY BIOSAFETY GUIDELINES</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE LABORATORY BIOSAFETY GUIDELINES</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * HANDLING AND PROCESSING SPECIMENS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * HANDLING AND PROCESSING SPECIMENS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE HANDLING AND PROCESSING SPECIMENS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE HANDLING AND PROCESSING SPECIMENS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * HANDLING AND PROCESSING SPECIMENS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE HANDLING AND PROCESSING SPECIMENS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * HANDLING AND PROCESSING SPECIMENS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE HANDLING AND PROCESSING SPECIMENS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * GENERAL GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * GENERAL GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT GENERAL GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT GENERAL GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * GENERAL GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT GENERAL GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * GENERAL GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT GENERAL GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * HANDLING *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * HANDLING *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT HANDLING *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT HANDLING</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * HANDLING</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT HANDLING *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * HANDLING</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT HANDLING</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * BULK-PACKAGED STERILE SWABS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * BULK-PACKAGED STERILE SWABS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT BULK-PACKAGED STERILE SWABS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT BULK-PACKAGED STERILE SWABS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * BULK-PACKAGED STERILE SWABS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT BULK-PACKAGED STERILE SWABS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * BULK-PACKAGED STERILE SWABS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT BULK-PACKAGED STERILE SWABS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * UPPER RESPIRATORY SAMPLE COLLECTION *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * UPPER RESPIRATORY SAMPLE COLLECTION *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT UPPER RESPIRATORY SAMPLE COLLECTION *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT UPPER RESPIRATORY SAMPLE COLLECTION</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * UPPER RESPIRATORY SAMPLE COLLECTION</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT UPPER RESPIRATORY SAMPLE COLLECTION *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * UPPER RESPIRATORY SAMPLE COLLECTION</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT UPPER RESPIRATORY SAMPLE COLLECTION</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * THIS PAGE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * THIS PAGE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE THIS PAGE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE THIS PAGE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * THIS PAGE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE THIS PAGE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * THIS PAGE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE THIS PAGE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * INTERIM GUIDANCE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * INTERIM GUIDANCE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE INTERIM GUIDANCE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE INTERIM GUIDANCE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * INTERIM GUIDANCE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE INTERIM GUIDANCE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * INTERIM GUIDANCE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE INTERIM GUIDANCE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * RESOURCES *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * RESOURCES *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE RESOURCES *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE RESOURCES</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * RESOURCES</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE RESOURCES *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * RESOURCES</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE RESOURCES</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * LABORATORY PROFESSIONALS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * LABORATORY PROFESSIONALS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE LABORATORY PROFESSIONALS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE LABORATORY PROFESSIONALS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * LABORATORY PROFESSIONALS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE LABORATORY PROFESSIONALS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * LABORATORY PROFESSIONALS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE LABORATORY PROFESSIONALS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * SPECIMENS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * SPECIMENS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE SPECIMENS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE SPECIMENS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * SPECIMENS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE SPECIMENS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * SPECIMENS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE SPECIMENS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * PERSONS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * PERSONS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE PERSONS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE PERSONS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * PERSONS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE PERSONS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * PERSONS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE PERSONS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * INVESTIGATION *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * INVESTIGATION *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE INVESTIGATION *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE INVESTIGATION</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * INVESTIGATION</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE INVESTIGATION *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * INVESTIGATION</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE INVESTIGATION</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * PUI *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * PUI *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE PUI *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE PUI</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * PUI</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE PUI *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * PUI</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE PUI</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE CORONAVIRUS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * CORONAVIRUS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * CORONAVIRUS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE CORONAVIRUS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * DISEASE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * DISEASE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE DISEASE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE DISEASE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * DISEASE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE DISEASE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * DISEASE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE DISEASE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE * THE IRR *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE * THE IRR *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE THE IRR *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE THE IRR</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE * THE IRR</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE THE IRR *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE * THE IRR</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE THE IRR</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE * REAGENTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE * REAGENTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE REAGENTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE REAGENTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE * REAGENTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE REAGENTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE * REAGENTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE REAGENTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE * SCIENTISTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE * SCIENTISTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE SCIENTISTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE SCIENTISTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE * SCIENTISTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE SCIENTISTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE * SCIENTISTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE SCIENTISTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE * BASIC RESEARCH *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE * BASIC RESEARCH *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE BASIC RESEARCH *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE BASIC RESEARCH</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE * BASIC RESEARCH</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE BASIC RESEARCH *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE * BASIC RESEARCH</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE BASIC RESEARCH</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE * IMPROVED VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE * IMPROVED VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE IMPROVED VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE IMPROVED VIRAL TESTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE * IMPROVED VIRAL TESTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE IMPROVED VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE * IMPROVED VIRAL TESTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE IMPROVED VIRAL TESTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE * VACCINES *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE * VACCINES *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE VACCINES *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE VACCINES</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE * VACCINES</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE VACCINES *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE * VACCINES</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE VACCINES</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE * DETECTION METHODS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE * DETECTION METHODS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE DETECTION METHODS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE DETECTION METHODS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE * DETECTION METHODS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACQUIRE DETECTION METHODS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE * DETECTION METHODS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACQUIRE DETECTION METHODS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * THE FEDERAL EMERGENCY MANAGEMENT AGENCY *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * THE FEDERAL EMERGENCY MANAGEMENT AGENCY *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY THE FEDERAL EMERGENCY MANAGEMENT AGENCY *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY THE FEDERAL EMERGENCY MANAGEMENT AGENCY</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * THE FEDERAL EMERGENCY MANAGEMENT AGENCY</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY THE FEDERAL EMERGENCY MANAGEMENT AGENCY *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * THE FEDERAL EMERGENCY MANAGEMENT AGENCY</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY THE FEDERAL EMERGENCY MANAGEMENT AGENCY</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * FEMA *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * FEMA *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY FEMA *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY FEMA</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * FEMA</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY FEMA *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * FEMA</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY FEMA</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * HHS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * HHS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY HHS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY HHS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * HHS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY HHS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * HHS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY HHS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * THE PROCESS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * THE PROCESS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY THE PROCESS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY THE PROCESS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * THE PROCESS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY THE PROCESS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * THE PROCESS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY THE PROCESS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * STATES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * STATES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY STATES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY STATES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * STATES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY STATES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * STATES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY STATES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * TERRITORIES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * TERRITORIES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY TERRITORIES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY TERRITORIES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * TERRITORIES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY TERRITORIES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * TERRITORIES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY TERRITORIES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * PUBLIC HEALTH LABS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * PUBLIC HEALTH LABS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY PUBLIC HEALTH LABS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY PUBLIC HEALTH LABS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * PUBLIC HEALTH LABS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY PUBLIC HEALTH LABS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * PUBLIC HEALTH LABS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY PUBLIC HEALTH LABS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * DIAGNOSTICS SUPPLIES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * DIAGNOSTICS SUPPLIES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY DIAGNOSTICS SUPPLIES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY DIAGNOSTICS SUPPLIES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * DIAGNOSTICS SUPPLIES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY DIAGNOSTICS SUPPLIES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * DIAGNOSTICS SUPPLIES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY DIAGNOSTICS SUPPLIES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * REAGENTS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * REAGENTS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY REAGENTS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY REAGENTS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * REAGENTS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY REAGENTS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * REAGENTS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY REAGENTS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * COVID-19 TESTING *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * COVID-19 TESTING *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY COVID-19 TESTING *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY COVID-19 TESTING</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * COVID-19 TESTING</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY COVID-19 TESTING *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * COVID-19 TESTING</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY COVID-19 TESTING</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * CHARGE *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * CHARGE *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY CHARGE *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY CHARGE</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * CHARGE</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY CHARGE *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * CHARGE</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY CHARGE</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * THE IRR *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * THE IRR *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY THE IRR *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY THE IRR</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY * THE IRR</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SIMPLIFY THE IRR *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY * THE IRR</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SIMPLIFY THE IRR</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * RECOMMENDATIONS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * RECOMMENDATIONS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE RECOMMENDATIONS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE RECOMMENDATIONS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * RECOMMENDATIONS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE RECOMMENDATIONS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * RECOMMENDATIONS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE RECOMMENDATIONS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * THE USE *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * THE USE *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE THE USE *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE THE USE</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * THE USE</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE THE USE *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * THE USE</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE THE USE</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * SEROLOGIC TESTS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * SEROLOGIC TESTS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE SEROLOGIC TESTS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE SEROLOGIC TESTS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * SEROLOGIC TESTS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE SEROLOGIC TESTS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * SEROLOGIC TESTS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE SEROLOGIC TESTS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * PROTECTIVE IMMUNITY *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * PROTECTIVE IMMUNITY *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE PROTECTIVE IMMUNITY *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE PROTECTIVE IMMUNITY</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * PROTECTIVE IMMUNITY</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE PROTECTIVE IMMUNITY *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * PROTECTIVE IMMUNITY</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE PROTECTIVE IMMUNITY</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * INFECTIOUSNESS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * INFECTIOUSNESS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE INFECTIOUSNESS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE INFECTIOUSNESS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * INFECTIOUSNESS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE INFECTIOUSNESS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * INFECTIOUSNESS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE INFECTIOUSNESS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * PERSONS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * PERSONS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE PERSONS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE PERSONS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * PERSONS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE PERSONS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * PERSONS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE PERSONS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * SAR-COV-2 *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * SAR-COV-2 *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE SAR-COV-2 *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE SAR-COV-2</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * SAR-COV-2</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE SAR-COV-2 *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * SAR-COV-2</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE SAR-COV-2</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * NEW INFORMATION *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * NEW INFORMATION *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE NEW INFORMATION *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE NEW INFORMATION</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE * NEW INFORMATION</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATE NEW INFORMATION *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE * NEW INFORMATION</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATE NEW INFORMATION</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW * INTERIM GUIDELINES *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW * INTERIM GUIDELINES *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW INTERIM GUIDELINES *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW INTERIM GUIDELINES</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW * INTERIM GUIDELINES</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW INTERIM GUIDELINES *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW * INTERIM GUIDELINES</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW INTERIM GUIDELINES</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW * HANDLING *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW * HANDLING *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW HANDLING *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW HANDLING</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW * HANDLING</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW HANDLING *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW * HANDLING</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW HANDLING</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW * TESTING CLINICAL SPECIMENS *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW * TESTING CLINICAL SPECIMENS *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW TESTING CLINICAL SPECIMENS *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW TESTING CLINICAL SPECIMENS</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW * TESTING CLINICAL SPECIMENS</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW TESTING CLINICAL SPECIMENS *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW * TESTING CLINICAL SPECIMENS</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW TESTING CLINICAL SPECIMENS</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW * PERSONS *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW * PERSONS *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW PERSONS *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW PERSONS</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW * PERSONS</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW PERSONS *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW * PERSONS</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW PERSONS</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW * CORONAVIRUS DISEASE *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW * CORONAVIRUS DISEASE *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW CORONAVIRUS DISEASE *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW CORONAVIRUS DISEASE</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW * CORONAVIRUS DISEASE</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW CORONAVIRUS DISEASE *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW * CORONAVIRUS DISEASE</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW CORONAVIRUS DISEASE</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW * STANDARD RECOMMENDED PROCEDURES *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW * STANDARD RECOMMENDED PROCEDURES *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW STANDARD RECOMMENDED PROCEDURES *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW STANDARD RECOMMENDED PROCEDURES</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW * STANDARD RECOMMENDED PROCEDURES</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FOLLOW STANDARD RECOMMENDED PROCEDURES *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW * STANDARD RECOMMENDED PROCEDURES</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FOLLOW STANDARD RECOMMENDED PROCEDURES</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE * MORE INFORMATION *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE * MORE INFORMATION *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE MORE INFORMATION *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE MORE INFORMATION</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE * MORE INFORMATION</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE MORE INFORMATION *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE * MORE INFORMATION</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE MORE INFORMATION</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE * PRECAUTIONS *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE * PRECAUTIONS *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE PRECAUTIONS *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE PRECAUTIONS</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE * PRECAUTIONS</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE PRECAUTIONS *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE * PRECAUTIONS</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE PRECAUTIONS</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE * SPECIMENS *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE * SPECIMENS *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE SPECIMENS *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE SPECIMENS</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE * SPECIMENS</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE SPECIMENS *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE * SPECIMENS</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE SPECIMENS</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE * SARS-COV-2 *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE * SARS-COV-2 *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE SARS-COV-2 *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE SARS-COV-2</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE * SARS-COV-2</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TAKE SARS-COV-2 *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE * SARS-COV-2</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TAKE SARS-COV-2</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * TIMELY COMMUNICATION *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * TIMELY COMMUNICATION *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE TIMELY COMMUNICATION *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE TIMELY COMMUNICATION</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * TIMELY COMMUNICATION</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE TIMELY COMMUNICATION *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * TIMELY COMMUNICATION</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE TIMELY COMMUNICATION</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * CLINICAL AND LABORATORY STAFF *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * CLINICAL AND LABORATORY STAFF *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE CLINICAL AND LABORATORY STAFF *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE CLINICAL AND LABORATORY STAFF</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * CLINICAL AND LABORATORY STAFF</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE CLINICAL AND LABORATORY STAFF *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * CLINICAL AND LABORATORY STAFF</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE CLINICAL AND LABORATORY STAFF</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE RISK *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE RISK *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE RISK *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE RISK</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE RISK</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE RISK *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE RISK</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE RISK</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * SPECIMENS *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * SPECIMENS *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE SPECIMENS *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE SPECIMENS</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * SPECIMENS</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE SPECIMENS *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * SPECIMENS</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE SPECIMENS</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * PATIENTS *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * PATIENTS *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE PATIENTS *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE PATIENTS</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * PATIENTS</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE PATIENTS *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * PATIENTS</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE PATIENTS</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * POSSIBLE SARS-COV-2 INFECTION *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * POSSIBLE SARS-COV-2 INFECTION *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE POSSIBLE SARS-COV-2 INFECTION *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE POSSIBLE SARS-COV-2 INFECTION</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * POSSIBLE SARS-COV-2 INFECTION</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE POSSIBLE SARS-COV-2 INFECTION *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * POSSIBLE SARS-COV-2 INFECTION</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE POSSIBLE SARS-COV-2 INFECTION</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * IT *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * IT *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE IT *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE IT</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * IT</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE IT *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * IT</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE IT</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THE NUMBER *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THE NUMBER *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THE NUMBER *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THE NUMBER</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THE NUMBER</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THE NUMBER *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THE NUMBER</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THE NUMBER</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * SARS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * SARS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE SARS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE SARS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * SARS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE SARS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * SARS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE SARS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * CDC LABS *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * CDC LABS *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE CDC LABS *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE CDC LABS</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * CDC LABS</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE CDC LABS *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * CDC LABS</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE CDC LABS</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * U. S. PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * U. S. PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE U. S. PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE U. S. PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * U. S. PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE U. S. PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * U. S. PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE U. S. PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE * THIS PAGE *</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE * THIS PAGE *</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE THIS PAGE *</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE THIS PAGE</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE * THIS PAGE</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE THIS PAGE *</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE * THIS PAGE</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE THIS PAGE</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE * KEY CDC LABORATORY ACTIVITIES *</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE * KEY CDC LABORATORY ACTIVITIES *</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE KEY CDC LABORATORY ACTIVITIES *</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE KEY CDC LABORATORY ACTIVITIES</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE * KEY CDC LABORATORY ACTIVITIES</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DESCRIBE KEY CDC LABORATORY ACTIVITIES *</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE * KEY CDC LABORATORY ACTIVITIES</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DESCRIBE KEY CDC LABORATORY ACTIVITIES</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THIS PAGE *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THIS PAGE *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THIS PAGE *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THIS PAGE</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THIS PAGE</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THIS PAGE *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THIS PAGE</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THIS PAGE</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * CLINICIANS *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * CLINICIANS *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE CLINICIANS *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE CLINICIANS</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * CLINICIANS</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE CLINICIANS *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * CLINICIANS</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE CLINICIANS</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * CRITERIA *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * CRITERIA *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE CRITERIA *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE CRITERIA</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * CRITERIA</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE CRITERIA *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * CRITERIA</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE CRITERIA</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * EVALUATION *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * EVALUATION *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE EVALUATION *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE EVALUATION</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * EVALUATION</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE EVALUATION *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * EVALUATION</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE EVALUATION</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * TESTING *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * TESTING *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE TESTING *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE TESTING</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * TESTING</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE TESTING *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * TESTING</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE TESTING</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PRIORITIZATION CRITERIA *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PRIORITIZATION CRITERIA *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PRIORITIZATION CRITERIA *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PRIORITIZATION CRITERIA</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PRIORITIZATION CRITERIA</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PRIORITIZATION CRITERIA *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PRIORITIZATION CRITERIA</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PRIORITIZATION CRITERIA</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * RECOMMENDATIONS *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * RECOMMENDATIONS *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE RECOMMENDATIONS *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE RECOMMENDATIONS</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * RECOMMENDATIONS</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE RECOMMENDATIONS *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * RECOMMENDATIONS</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE RECOMMENDATIONS</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * REPORTING *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * REPORTING *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE REPORTING *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE REPORTING</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * REPORTING</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE REPORTING *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * REPORTING</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE REPORTING</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * SPECIMEN COLLECTION *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * SPECIMEN COLLECTION *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE SPECIMEN COLLECTION *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE SPECIMEN COLLECTION</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * SPECIMEN COLLECTION</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE SPECIMEN COLLECTION *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * SPECIMEN COLLECTION</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE SPECIMEN COLLECTION</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * SEVERAL OTHER FEDERAL AGENCIES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * SEVERAL OTHER FEDERAL AGENCIES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH SEVERAL OTHER FEDERAL AGENCIES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH SEVERAL OTHER FEDERAL AGENCIES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * SEVERAL OTHER FEDERAL AGENCIES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH SEVERAL OTHER FEDERAL AGENCIES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * SEVERAL OTHER FEDERAL AGENCIES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH SEVERAL OTHER FEDERAL AGENCIES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * THIS CRITICAL EFFORT *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * THIS CRITICAL EFFORT *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH THIS CRITICAL EFFORT *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH THIS CRITICAL EFFORT</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * THIS CRITICAL EFFORT</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH THIS CRITICAL EFFORT *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * THIS CRITICAL EFFORT</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH THIS CRITICAL EFFORT</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * THIS REPOSITORY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * THIS REPOSITORY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH THIS REPOSITORY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH THIS REPOSITORY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * THIS REPOSITORY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH THIS REPOSITORY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * THIS REPOSITORY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH THIS REPOSITORY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * THE NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * THE NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH THE NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH THE NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * THE NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH THE NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * THE NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH THE NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * ALLERGY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * ALLERGY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH ALLERGY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH ALLERGY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * ALLERGY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH ALLERGY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * ALLERGY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH ALLERGY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * THE NATIONAL INSTITUTES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * THE NATIONAL INSTITUTES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH THE NATIONAL INSTITUTES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH THE NATIONAL INSTITUTES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * THE NATIONAL INSTITUTES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH THE NATIONAL INSTITUTES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * THE NATIONAL INSTITUTES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH THE NATIONAL INSTITUTES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * HEALTH *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * HEALTH *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH HEALTH *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH HEALTH</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * HEALTH</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH HEALTH *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * HEALTH</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH HEALTH</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * REAGENTS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * REAGENTS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH REAGENTS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH REAGENTS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * REAGENTS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH REAGENTS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * REAGENTS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH REAGENTS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * TOOLS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * TOOLS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH TOOLS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH TOOLS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * TOOLS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH TOOLS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * TOOLS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH TOOLS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * INFORMATION *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * INFORMATION *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH INFORMATION *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH INFORMATION</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * INFORMATION</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH INFORMATION *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * INFORMATION</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH INFORMATION</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * AGENTS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * AGENTS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH AGENTS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH AGENTS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * AGENTS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH AGENTS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * AGENTS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH AGENTS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * NON-PATHOGENIC MICROBES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * NON-PATHOGENIC MICROBES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH NON-PATHOGENIC MICROBES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH NON-PATHOGENIC MICROBES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * NON-PATHOGENIC MICROBES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH NON-PATHOGENIC MICROBES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * NON-PATHOGENIC MICROBES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH NON-PATHOGENIC MICROBES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * OTHER MICROBIOLOGICAL MATERIALS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * OTHER MICROBIOLOGICAL MATERIALS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH OTHER MICROBIOLOGICAL MATERIALS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH OTHER MICROBIOLOGICAL MATERIALS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * OTHER MICROBIOLOGICAL MATERIALS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH OTHER MICROBIOLOGICAL MATERIALS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * OTHER MICROBIOLOGICAL MATERIALS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH OTHER MICROBIOLOGICAL MATERIALS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * RELEVANCE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * RELEVANCE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH RELEVANCE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH RELEVANCE</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * RELEVANCE</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH RELEVANCE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * RELEVANCE</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH RELEVANCE</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * THE RESEARCH COMMUNITY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * THE RESEARCH COMMUNITY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH THE RESEARCH COMMUNITY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH THE RESEARCH COMMUNITY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * THE RESEARCH COMMUNITY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH THE RESEARCH COMMUNITY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * THE RESEARCH COMMUNITY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH THE RESEARCH COMMUNITY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * DIAGNOSTIC DEVELOPERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * DIAGNOSTIC DEVELOPERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH DIAGNOSTIC DEVELOPERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH DIAGNOSTIC DEVELOPERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH * DIAGNOSTIC DEVELOPERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESTABLISH DIAGNOSTIC DEVELOPERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH * DIAGNOSTIC DEVELOPERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESTABLISH DIAGNOSTIC DEVELOPERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * FDA *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * FDA *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE FDA *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE FDA</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * FDA</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE FDA *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * FDA</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE FDA</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * FAQS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * FAQS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE FAQS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE FAQS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * FAQS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE FAQS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * FAQS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE FAQS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * DIAGNOSTIC TESTING *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * DIAGNOSTIC TESTING *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE DIAGNOSTIC TESTING *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE DIAGNOSTIC TESTING</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * DIAGNOSTIC TESTING</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE DIAGNOSTIC TESTING *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * DIAGNOSTIC TESTING</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE DIAGNOSTIC TESTING</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * ANSWERS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * ANSWERS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE ANSWERS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE ANSWERS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * ANSWERS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE ANSWERS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * ANSWERS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE ANSWERS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * QUESTIONS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * QUESTIONS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE QUESTIONS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE QUESTIONS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * QUESTIONS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE QUESTIONS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * QUESTIONS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE QUESTIONS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THE DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THE DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THE DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THE DEVELOPMENT</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * THE DEVELOPMENT</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE THE DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * THE DEVELOPMENT</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE THE DEVELOPMENT</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PERFORMANCE *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PERFORMANCE *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PERFORMANCE *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PERFORMANCE</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * PERFORMANCE</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE PERFORMANCE *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * PERFORMANCE</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE PERFORMANCE</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE VIRAL TESTS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * VIRAL TESTS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * VIRAL TESTS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE VIRAL TESTS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * SARS-COV-2 *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * SARS-COV-2 *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE SARS-COV-2 *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE SARS-COV-2</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE * SARS-COV-2</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVIDE SARS-COV-2 *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE * SARS-COV-2</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVIDE SARS-COV-2</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE * THE U. S. DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE * THE U. S. DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE THE U. S. DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE THE U. S. DEPARTMENT</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE * THE U. S. DEPARTMENT</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE THE U. S. DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE * THE U. S. DEPARTMENT</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE THE U. S. DEPARTMENT</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE * HEALTH *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE * HEALTH *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE HEALTH *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE HEALTH</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE * HEALTH</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE HEALTH *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE * HEALTH</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE HEALTH</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE * HUMAN SERVICES *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE * HUMAN SERVICES *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE HUMAN SERVICES *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE HUMAN SERVICES</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE * HUMAN SERVICES</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE HUMAN SERVICES *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE * HUMAN SERVICES</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE HUMAN SERVICES</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE * THE ID *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE * THE ID *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE THE ID *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE THE ID</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE * THE ID</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PURCHASE THE ID *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE * THE ID</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PURCHASE THE ID</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * ASSOCIATION *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * ASSOCIATION *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT ASSOCIATION *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT ASSOCIATION</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * ASSOCIATION</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT ASSOCIATION *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * ASSOCIATION</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT ASSOCIATION</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * PUBLIC HEALTH LABORATORIES APHL *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * PUBLIC HEALTH LABORATORIES APHL *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT PUBLIC HEALTH LABORATORIES APHL *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT PUBLIC HEALTH LABORATORIES APHL</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * PUBLIC HEALTH LABORATORIES APHL</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT PUBLIC HEALTH LABORATORIES APHL *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * PUBLIC HEALTH LABORATORIES APHL</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT PUBLIC HEALTH LABORATORIES APHL</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * MEMBER LABORATORIES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * MEMBER LABORATORIES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT MEMBER LABORATORIES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT MEMBER LABORATORIES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * MEMBER LABORATORIES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT MEMBER LABORATORIES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * MEMBER LABORATORIES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT MEMBER LABORATORIES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * THE COVID-19 PANDEMIC *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * THE COVID-19 PANDEMIC *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT THE COVID-19 PANDEMIC *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT THE COVID-19 PANDEMIC</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * THE COVID-19 PANDEMIC</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT THE COVID-19 PANDEMIC *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * THE COVID-19 PANDEMIC</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT THE COVID-19 PANDEMIC</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * QUALITY TESTING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * QUALITY TESTING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT QUALITY TESTING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT QUALITY TESTING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * QUALITY TESTING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT QUALITY TESTING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * QUALITY TESTING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT QUALITY TESTING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * REPORTING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * REPORTING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT REPORTING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT REPORTING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * REPORTING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT REPORTING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * REPORTING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT REPORTING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * TECHNICAL ASSISTANCE *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * TECHNICAL ASSISTANCE *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT TECHNICAL ASSISTANCE *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT TECHNICAL ASSISTANCE</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * TECHNICAL ASSISTANCE</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT TECHNICAL ASSISTANCE *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * TECHNICAL ASSISTANCE</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT TECHNICAL ASSISTANCE</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * COMMUNICATIONS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * COMMUNICATIONS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT COMMUNICATIONS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT COMMUNICATIONS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT * COMMUNICATIONS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT COMMUNICATIONS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT * COMMUNICATIONS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT COMMUNICATIONS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING * LARGE-SCALE, RAPID GENOMIC SEQUENCING *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING * LARGE-SCALE, RAPID GENOMIC SEQUENCING *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING LARGE-SCALE, RAPID GENOMIC SEQUENCING *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING LARGE-SCALE, RAPID GENOMIC SEQUENCING</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING * LARGE-SCALE, RAPID GENOMIC SEQUENCING</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING LARGE-SCALE, RAPID GENOMIC SEQUENCING *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING * LARGE-SCALE, RAPID GENOMIC SEQUENCING</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING LARGE-SCALE, RAPID GENOMIC SEQUENCING</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING * THE VIRUS *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING * THE VIRUS *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING THE VIRUS *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING THE VIRUS</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING * THE VIRUS</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING THE VIRUS *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING * THE VIRUS</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING THE VIRUS</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING * THE COVID-19 RESPONSE CDC *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING * THE COVID-19 RESPONSE CDC *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING THE COVID-19 RESPONSE CDC *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING THE COVID-19 RESPONSE CDC</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING * THE COVID-19 RESPONSE CDC</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING THE COVID-19 RESPONSE CDC *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING * THE COVID-19 RESPONSE CDC</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING THE COVID-19 RESPONSE CDC</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING * PUBLIC HEALTH EXPERTS *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING * PUBLIC HEALTH EXPERTS *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING PUBLIC HEALTH EXPERTS *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING PUBLIC HEALTH EXPERTS</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING * PUBLIC HEALTH EXPERTS</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING PUBLIC HEALTH EXPERTS *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING * PUBLIC HEALTH EXPERTS</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING PUBLIC HEALTH EXPERTS</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING * IMPORTANT CHANGES *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING * IMPORTANT CHANGES *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING IMPORTANT CHANGES *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING IMPORTANT CHANGES</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING * IMPORTANT CHANGES</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING IMPORTANT CHANGES *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING * IMPORTANT CHANGES</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING IMPORTANT CHANGES</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING * IT *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING * IT *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING IT *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING IT</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING * IT</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING IT *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING * IT</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING IT</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * EXTENSIVE PARTICIPATION *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * EXTENSIVE PARTICIPATION *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM EXTENSIVE PARTICIPATION *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM EXTENSIVE PARTICIPATION</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * EXTENSIVE PARTICIPATION</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM EXTENSIVE PARTICIPATION *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * EXTENSIVE PARTICIPATION</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM EXTENSIVE PARTICIPATION</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * US CLINICAL AND PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * US CLINICAL AND PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM US CLINICAL AND PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM US CLINICAL AND PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * US CLINICAL AND PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM US CLINICAL AND PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * US CLINICAL AND PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM US CLINICAL AND PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * ACADEMIC INSTITUTIONS *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * ACADEMIC INSTITUTIONS *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM ACADEMIC INSTITUTIONS *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM ACADEMIC INSTITUTIONS</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * ACADEMIC INSTITUTIONS</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM ACADEMIC INSTITUTIONS *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * ACADEMIC INSTITUTIONS</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM ACADEMIC INSTITUTIONS</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * THE PRIVATE SECTOR *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * THE PRIVATE SECTOR *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM THE PRIVATE SECTOR *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM THE PRIVATE SECTOR</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * THE PRIVATE SECTOR</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM THE PRIVATE SECTOR *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * THE PRIVATE SECTOR</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM THE PRIVATE SECTOR</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * INFORMATION *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * INFORMATION *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM INFORMATION *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM INFORMATION</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * INFORMATION</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM INFORMATION *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * INFORMATION</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM INFORMATION</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * THE VIRUS *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * THE VIRUS *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM THE VIRUS *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM THE VIRUS</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * THE VIRUS</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM THE VIRUS *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * THE VIRUS</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM THE VIRUS</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * COVID-19 MITIGATION STRATEGIES *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * COVID-19 MITIGATION STRATEGIES *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM COVID-19 MITIGATION STRATEGIES *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM COVID-19 MITIGATION STRATEGIES</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * COVID-19 MITIGATION STRATEGIES</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM COVID-19 MITIGATION STRATEGIES *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * COVID-19 MITIGATION STRATEGIES</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM COVID-19 MITIGATION STRATEGIES</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * AMD *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * AMD *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD AMD *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD AMD</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * AMD</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD AMD *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * AMD</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD AMD</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * THE PAST SIX YEARS *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * THE PAST SIX YEARS *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD THE PAST SIX YEARS *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD THE PAST SIX YEARS</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * THE PAST SIX YEARS</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD THE PAST SIX YEARS *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * THE PAST SIX YEARS</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD THE PAST SIX YEARS</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * FEDERAL, STATE, AND LOCAL PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * FEDERAL, STATE, AND LOCAL PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD FEDERAL, STATE, AND LOCAL PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD FEDERAL, STATE, AND LOCAL PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * FEDERAL, STATE, AND LOCAL PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD FEDERAL, STATE, AND LOCAL PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * FEDERAL, STATE, AND LOCAL PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD FEDERAL, STATE, AND LOCAL PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * THE USE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * THE USE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD THE USE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD THE USE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * THE USE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD THE USE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * THE USE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD THE USE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * PATHOGEN GENOMICS *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * PATHOGEN GENOMICS *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD PATHOGEN GENOMICS *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD PATHOGEN GENOMICS</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * PATHOGEN GENOMICS</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD PATHOGEN GENOMICS *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * PATHOGEN GENOMICS</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD PATHOGEN GENOMICS</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * OTHER ADVANCED LABORATORY TECHNOLOGIES *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * OTHER ADVANCED LABORATORY TECHNOLOGIES *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD OTHER ADVANCED LABORATORY TECHNOLOGIES *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD OTHER ADVANCED LABORATORY TECHNOLOGIES</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * OTHER ADVANCED LABORATORY TECHNOLOGIES</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD OTHER ADVANCED LABORATORY TECHNOLOGIES *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * OTHER ADVANCED LABORATORY TECHNOLOGIES</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD OTHER ADVANCED LABORATORY TECHNOLOGIES</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * INFECTIOUS DISEASE SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * INFECTIOUS DISEASE SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD INFECTIOUS DISEASE SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD INFECTIOUS DISEASE SURVEILLANCE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * INFECTIOUS DISEASE SURVEILLANCE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD INFECTIOUS DISEASE SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * INFECTIOUS DISEASE SURVEILLANCE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD INFECTIOUS DISEASE SURVEILLANCE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * OUTBREAK RESPONSE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * OUTBREAK RESPONSE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD OUTBREAK RESPONSE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD OUTBREAK RESPONSE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD * OUTBREAK RESPONSE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LEAD OUTBREAK RESPONSE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD * OUTBREAK RESPONSE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LEAD OUTBREAK RESPONSE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * SPHERES *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * SPHERES *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM SPHERES *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM SPHERES</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * SPHERES</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM SPHERES *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * SPHERES</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM SPHERES</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * THE USE *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * THE USE *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM THE USE *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM THE USE</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * THE USE</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM THE USE *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * THE USE</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM THE USE</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * REAL-TIME PATHOGEN SEQUENCE DATA *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * REAL-TIME PATHOGEN SEQUENCE DATA *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM REAL-TIME PATHOGEN SEQUENCE DATA *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM REAL-TIME PATHOGEN SEQUENCE DATA</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * REAL-TIME PATHOGEN SEQUENCE DATA</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM REAL-TIME PATHOGEN SEQUENCE DATA *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * REAL-TIME PATHOGEN SEQUENCE DATA</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM REAL-TIME PATHOGEN SEQUENCE DATA</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * MOLECULAR EPIDEMIOLOGY *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * MOLECULAR EPIDEMIOLOGY *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM MOLECULAR EPIDEMIOLOGY *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM MOLECULAR EPIDEMIOLOGY</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * MOLECULAR EPIDEMIOLOGY</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM MOLECULAR EPIDEMIOLOGY *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * MOLECULAR EPIDEMIOLOGY</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM MOLECULAR EPIDEMIOLOGY</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * THE THE COVID-19 RESPONSE CDC PANDEMIC RESPONSE *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * THE THE COVID-19 RESPONSE CDC PANDEMIC RESPONSE *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM THE THE COVID-19 RESPONSE CDC PANDEMIC RESPONSE *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM THE THE COVID-19 RESPONSE CDC PANDEMIC RESPONSE</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM * THE THE COVID-19 RESPONSE CDC PANDEMIC RESPONSE</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AIM THE THE COVID-19 RESPONSE CDC PANDEMIC RESPONSE *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM * THE THE COVID-19 RESPONSE CDC PANDEMIC RESPONSE</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AIM THE THE COVID-19 RESPONSE CDC PANDEMIC RESPONSE</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENGAGE * US CLINICAL, ACADEMIC, AND COMMERCIAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENGAGE * US CLINICAL, ACADEMIC, AND COMMERCIAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENGAGE US CLINICAL, ACADEMIC, AND COMMERCIAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENGAGE US CLINICAL, ACADEMIC, AND COMMERCIAL LABORATORIES</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENGAGE * US CLINICAL, ACADEMIC, AND COMMERCIAL LABORATORIES</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENGAGE US CLINICAL, ACADEMIC, AND COMMERCIAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENGAGE * US CLINICAL, ACADEMIC, AND COMMERCIAL LABORATORIES</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENGAGE US CLINICAL, ACADEMIC, AND COMMERCIAL LABORATORIES</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENGAGE * SARS-COV-2 DATA *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENGAGE * SARS-COV-2 DATA *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENGAGE SARS-COV-2 DATA *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENGAGE SARS-COV-2 DATA</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENGAGE * SARS-COV-2 DATA</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENGAGE SARS-COV-2 DATA *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENGAGE * SARS-COV-2 DATA</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENGAGE SARS-COV-2 DATA</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENGAGE * ANY SCALE *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENGAGE * ANY SCALE *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENGAGE ANY SCALE *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENGAGE ANY SCALE</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENGAGE * ANY SCALE</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENGAGE ANY SCALE *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENGAGE * ANY SCALE</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENGAGE ANY SCALE</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * 37 STATE AND LOCAL PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * 37 STATE AND LOCAL PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE 37 STATE AND LOCAL PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE 37 STATE AND LOCAL PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * 37 STATE AND LOCAL PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE 37 STATE AND LOCAL PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * 37 STATE AND LOCAL PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE 37 STATE AND LOCAL PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * SEVERAL LARGE REGIONAL AND NATIONAL CLINICAL DIAGNOSTIC CORPORATIONS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * SEVERAL LARGE REGIONAL AND NATIONAL CLINICAL DIAGNOSTIC CORPORATIONS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE SEVERAL LARGE REGIONAL AND NATIONAL CLINICAL DIAGNOSTIC CORPORATIONS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE SEVERAL LARGE REGIONAL AND NATIONAL CLINICAL DIAGNOSTIC CORPORATIONS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * SEVERAL LARGE REGIONAL AND NATIONAL CLINICAL DIAGNOSTIC CORPORATIONS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE SEVERAL LARGE REGIONAL AND NATIONAL CLINICAL DIAGNOSTIC CORPORATIONS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * SEVERAL LARGE REGIONAL AND NATIONAL CLINICAL DIAGNOSTIC CORPORATIONS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE SEVERAL LARGE REGIONAL AND NATIONAL CLINICAL DIAGNOSTIC CORPORATIONS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * ACADEMIC AND NON-PROFIT LEADERS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * ACADEMIC AND NON-PROFIT LEADERS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE ACADEMIC AND NON-PROFIT LEADERS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE ACADEMIC AND NON-PROFIT LEADERS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * ACADEMIC AND NON-PROFIT LEADERS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE ACADEMIC AND NON-PROFIT LEADERS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * ACADEMIC AND NON-PROFIT LEADERS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE ACADEMIC AND NON-PROFIT LEADERS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * PATHOGEN GENOMICS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * PATHOGEN GENOMICS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE PATHOGEN GENOMICS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE PATHOGEN GENOMICS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * PATHOGEN GENOMICS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE PATHOGEN GENOMICS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * PATHOGEN GENOMICS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE PATHOGEN GENOMICS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * BIOINFORMATICS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * BIOINFORMATICS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE BIOINFORMATICS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE BIOINFORMATICS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * BIOINFORMATICS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE BIOINFORMATICS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * BIOINFORMATICS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE BIOINFORMATICS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * PUBLIC HEALTH *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * PUBLIC HEALTH *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE PUBLIC HEALTH *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE PUBLIC HEALTH</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * PUBLIC HEALTH</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE PUBLIC HEALTH *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * PUBLIC HEALTH</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE PUBLIC HEALTH</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * THE COUNTRY *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * THE COUNTRY *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE THE COUNTRY *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE THE COUNTRY</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE * THE COUNTRY</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCLUDE THE COUNTRY *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE * THE COUNTRY</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCLUDE THE COUNTRY</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * FEDERAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * FEDERAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN FEDERAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN FEDERAL LABORATORIES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * FEDERAL LABORATORIES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN FEDERAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * FEDERAL LABORATORIES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN FEDERAL LABORATORIES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * PUBLIC HEALTH AGENCIES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * PUBLIC HEALTH AGENCIES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN PUBLIC HEALTH AGENCIES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN PUBLIC HEALTH AGENCIES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * PUBLIC HEALTH AGENCIES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN PUBLIC HEALTH AGENCIES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * PUBLIC HEALTH AGENCIES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN PUBLIC HEALTH AGENCIES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * INTERNATIONAL GENOMICS EFFORTS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * INTERNATIONAL GENOMICS EFFORTS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN INTERNATIONAL GENOMICS EFFORTS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN INTERNATIONAL GENOMICS EFFORTS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * INTERNATIONAL GENOMICS EFFORTS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN INTERNATIONAL GENOMICS EFFORTS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * INTERNATIONAL GENOMICS EFFORTS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN INTERNATIONAL GENOMICS EFFORTS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * THE PRIVATE SECTOR *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * THE PRIVATE SECTOR *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN THE PRIVATE SECTOR *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN THE PRIVATE SECTOR</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * THE PRIVATE SECTOR</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN THE PRIVATE SECTOR *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * THE PRIVATE SECTOR</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN THE PRIVATE SECTOR</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * EFFORTS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * EFFORTS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN EFFORTS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN EFFORTS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * EFFORTS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN EFFORTS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * EFFORTS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN EFFORTS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * THE GENOMICS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * THE GENOMICS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN THE GENOMICS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN THE GENOMICS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * THE GENOMICS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN THE GENOMICS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * THE GENOMICS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN THE GENOMICS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * PATTERNS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * PATTERNS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN PATTERNS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN PATTERNS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * PATTERNS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN PATTERNS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * PATTERNS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN PATTERNS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * SARS-COV-2 TRANSMISSION *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * SARS-COV-2 TRANSMISSION *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN SARS-COV-2 TRANSMISSION *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN SARS-COV-2 TRANSMISSION</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * SARS-COV-2 TRANSMISSION</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN SARS-COV-2 TRANSMISSION *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * SARS-COV-2 TRANSMISSION</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN SARS-COV-2 TRANSMISSION</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN THE UNITED STATES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN * THE UNITED STATES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALIGN THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN * THE UNITED STATES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALIGN THE UNITED STATES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * 8 CORE OBJECTIVES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * 8 CORE OBJECTIVES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE 8 CORE OBJECTIVES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE 8 CORE OBJECTIVES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * 8 CORE OBJECTIVES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE 8 CORE OBJECTIVES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * 8 CORE OBJECTIVES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE 8 CORE OBJECTIVES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * A NETWORK *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * A NETWORK *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE A NETWORK *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE A NETWORK</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * A NETWORK</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE A NETWORK *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * A NETWORK</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE A NETWORK</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * SEQUENCING LABORATORIES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * SEQUENCING LABORATORIES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE SEQUENCING LABORATORIES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE SEQUENCING LABORATORIES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * SEQUENCING LABORATORIES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE SEQUENCING LABORATORIES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * SEQUENCING LABORATORIES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE SEQUENCING LABORATORIES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * BIOINFORMATICS CAPACITY *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * BIOINFORMATICS CAPACITY *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE BIOINFORMATICS CAPACITY *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE BIOINFORMATICS CAPACITY</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * BIOINFORMATICS CAPACITY</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE BIOINFORMATICS CAPACITY *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * BIOINFORMATICS CAPACITY</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE BIOINFORMATICS CAPACITY</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * SUBJECT MATTER EXPERTISE *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * SUBJECT MATTER EXPERTISE *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE SUBJECT MATTER EXPERTISE *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE SUBJECT MATTER EXPERTISE</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * SUBJECT MATTER EXPERTISE</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE SUBJECT MATTER EXPERTISE *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * SUBJECT MATTER EXPERTISE</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE SUBJECT MATTER EXPERTISE</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * THE UMBRELLA *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * THE UMBRELLA *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE THE UMBRELLA *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE THE UMBRELLA</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * THE UMBRELLA</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE THE UMBRELLA *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * THE UMBRELLA</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE THE UMBRELLA</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * A MASSIVE AND COORDINATED PUBLIC HEALTH SEQUENCING EFFORT *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * A MASSIVE AND COORDINATED PUBLIC HEALTH SEQUENCING EFFORT *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE A MASSIVE AND COORDINATED PUBLIC HEALTH SEQUENCING EFFORT *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE A MASSIVE AND COORDINATED PUBLIC HEALTH SEQUENCING EFFORT</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE * A MASSIVE AND COORDINATED PUBLIC HEALTH SEQUENCING EFFORT</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HAVE A MASSIVE AND COORDINATED PUBLIC HEALTH SEQUENCING EFFORT *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE * A MASSIVE AND COORDINATED PUBLIC HEALTH SEQUENCING EFFORT</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HAVE A MASSIVE AND COORDINATED PUBLIC HEALTH SEQUENCING EFFORT</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * SPHERES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * SPHERES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE SPHERES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE SPHERES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * SPHERES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE SPHERES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * SPHERES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE SPHERES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * A CONSORTIUM *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * A CONSORTIUM *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE A CONSORTIUM *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE A CONSORTIUM</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * A CONSORTIUM</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE A CONSORTIUM *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * A CONSORTIUM</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE A CONSORTIUM</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE US PUBLIC HEALTH AND SCIENTIFIC COMMUNITY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE US PUBLIC HEALTH AND SCIENTIFIC COMMUNITY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE US PUBLIC HEALTH AND SCIENTIFIC COMMUNITY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE US PUBLIC HEALTH AND SCIENTIFIC COMMUNITY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * THE US PUBLIC HEALTH AND SCIENTIFIC COMMUNITY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE THE US PUBLIC HEALTH AND SCIENTIFIC COMMUNITY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * THE US PUBLIC HEALTH AND SCIENTIFIC COMMUNITY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE THE US PUBLIC HEALTH AND SCIENTIFIC COMMUNITY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * CENTERS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * CENTERS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE CENTERS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE CENTERS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * CENTERS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE CENTERS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * CENTERS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE CENTERS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * DISEASE CONTROL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * DISEASE CONTROL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE DISEASE CONTROL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE DISEASE CONTROL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * DISEASE CONTROL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE DISEASE CONTROL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * DISEASE CONTROL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE DISEASE CONTROL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * PREVENTION *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * PREVENTION *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE PREVENTION *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE PREVENTION</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * PREVENTION</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE PREVENTION *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * PREVENTION</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE PREVENTION</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * OFFICE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * OFFICE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE OFFICE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE OFFICE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * OFFICE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE OFFICE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * OFFICE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE OFFICE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * ADVANCED MOLECULAR DETECTION NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * ADVANCED MOLECULAR DETECTION NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE ADVANCED MOLECULAR DETECTION NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE ADVANCED MOLECULAR DETECTION NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * ADVANCED MOLECULAR DETECTION NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE ADVANCED MOLECULAR DETECTION NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * ADVANCED MOLECULAR DETECTION NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE ADVANCED MOLECULAR DETECTION NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * ALLERGY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * ALLERGY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE ALLERGY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE ALLERGY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * ALLERGY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE ALLERGY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * ALLERGY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE ALLERGY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * GENOMICS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * GENOMICS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE GENOMICS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE GENOMICS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * GENOMICS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE GENOMICS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * GENOMICS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE GENOMICS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * ADVANCED TECHNOLOGY NATIONAL INSTITUTES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * ADVANCED TECHNOLOGY NATIONAL INSTITUTES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE ADVANCED TECHNOLOGY NATIONAL INSTITUTES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE ADVANCED TECHNOLOGY NATIONAL INSTITUTES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * ADVANCED TECHNOLOGY NATIONAL INSTITUTES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE ADVANCED TECHNOLOGY NATIONAL INSTITUTES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * ADVANCED TECHNOLOGY NATIONAL INSTITUTES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE ADVANCED TECHNOLOGY NATIONAL INSTITUTES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * HEALTH *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * HEALTH *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE HEALTH *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE HEALTH</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * HEALTH</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE HEALTH *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * HEALTH</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE HEALTH</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * NATIONAL HUMAN GENOME RESEARCH INSTITUTE NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * NATIONAL HUMAN GENOME RESEARCH INSTITUTE NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE NATIONAL HUMAN GENOME RESEARCH INSTITUTE NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE NATIONAL HUMAN GENOME RESEARCH INSTITUTE NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * NATIONAL HUMAN GENOME RESEARCH INSTITUTE NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE NATIONAL HUMAN GENOME RESEARCH INSTITUTE NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * NATIONAL HUMAN GENOME RESEARCH INSTITUTE NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE NATIONAL HUMAN GENOME RESEARCH INSTITUTE NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * STANDARDS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * STANDARDS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE STANDARDS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE STANDARDS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * STANDARDS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE STANDARDS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * STANDARDS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE STANDARDS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * TECHNOLOGY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * TECHNOLOGY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE TECHNOLOGY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE TECHNOLOGY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * TECHNOLOGY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE TECHNOLOGY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * TECHNOLOGY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE TECHNOLOGY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * NATIONAL LIBRARY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * NATIONAL LIBRARY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE NATIONAL LIBRARY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE NATIONAL LIBRARY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * NATIONAL LIBRARY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE NATIONAL LIBRARY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * NATIONAL LIBRARY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE NATIONAL LIBRARY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * MEDICINE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * MEDICINE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE MEDICINE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE MEDICINE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * MEDICINE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE MEDICINE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * MEDICINE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE MEDICINE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * BIOTECHNOLOGY INFORMATION UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * BIOTECHNOLOGY INFORMATION UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE BIOTECHNOLOGY INFORMATION UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE BIOTECHNOLOGY INFORMATION UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * BIOTECHNOLOGY INFORMATION UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE BIOTECHNOLOGY INFORMATION UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * BIOTECHNOLOGY INFORMATION UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE BIOTECHNOLOGY INFORMATION UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * INFECTIOUS DISEASES​​ WALTER REED ARMY INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * INFECTIOUS DISEASES​​ WALTER REED ARMY INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE INFECTIOUS DISEASES​​ WALTER REED ARMY INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE INFECTIOUS DISEASES​​ WALTER REED ARMY INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * INFECTIOUS DISEASES​​ WALTER REED ARMY INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE INFECTIOUS DISEASES​​ WALTER REED ARMY INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * INFECTIOUS DISEASES​​ WALTER REED ARMY INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE INFECTIOUS DISEASES​​ WALTER REED ARMY INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * RESEARCH STATE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * RESEARCH STATE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE RESEARCH STATE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE RESEARCH STATE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * RESEARCH STATE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE RESEARCH STATE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * RESEARCH STATE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE RESEARCH STATE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * LOCAL PUBLIC HEALTH LABORATORIES MOUNT SINAI SCHOOL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * LOCAL PUBLIC HEALTH LABORATORIES MOUNT SINAI SCHOOL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE LOCAL PUBLIC HEALTH LABORATORIES MOUNT SINAI SCHOOL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE LOCAL PUBLIC HEALTH LABORATORIES MOUNT SINAI SCHOOL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * LOCAL PUBLIC HEALTH LABORATORIES MOUNT SINAI SCHOOL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE LOCAL PUBLIC HEALTH LABORATORIES MOUNT SINAI SCHOOL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * LOCAL PUBLIC HEALTH LABORATORIES MOUNT SINAI SCHOOL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE LOCAL PUBLIC HEALTH LABORATORIES MOUNT SINAI SCHOOL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * OREGON HEALTH AND SCIENCE UNIVERSITY NON-PROFIT PUBLIC HEALTH AND RESEARCH LABORATORIES ASSOCIATION *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * OREGON HEALTH AND SCIENCE UNIVERSITY NON-PROFIT PUBLIC HEALTH AND RESEARCH LABORATORIES ASSOCIATION *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE OREGON HEALTH AND SCIENCE UNIVERSITY NON-PROFIT PUBLIC HEALTH AND RESEARCH LABORATORIES ASSOCIATION *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE OREGON HEALTH AND SCIENCE UNIVERSITY NON-PROFIT PUBLIC HEALTH AND RESEARCH LABORATORIES ASSOCIATION</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * OREGON HEALTH AND SCIENCE UNIVERSITY NON-PROFIT PUBLIC HEALTH AND RESEARCH LABORATORIES ASSOCIATION</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE OREGON HEALTH AND SCIENCE UNIVERSITY NON-PROFIT PUBLIC HEALTH AND RESEARCH LABORATORIES ASSOCIATION *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * OREGON HEALTH AND SCIENCE UNIVERSITY NON-PROFIT PUBLIC HEALTH AND RESEARCH LABORATORIES ASSOCIATION</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE OREGON HEALTH AND SCIENCE UNIVERSITY NON-PROFIT PUBLIC HEALTH AND RESEARCH LABORATORIES ASSOCIATION</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * PUBLIC HEALTH LABORATORIES BILL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * PUBLIC HEALTH LABORATORIES BILL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE PUBLIC HEALTH LABORATORIES BILL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE PUBLIC HEALTH LABORATORIES BILL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * PUBLIC HEALTH LABORATORIES BILL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE PUBLIC HEALTH LABORATORIES BILL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * PUBLIC HEALTH LABORATORIES BILL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE PUBLIC HEALTH LABORATORIES BILL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * MELINDA GATES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * MELINDA GATES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE MELINDA GATES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE MELINDA GATES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE * MELINDA GATES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BE MELINDA GATES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE * MELINDA GATES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BE MELINDA GATES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * ADDITIONAL INFORMATION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * ADDITIONAL INFORMATION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH ADDITIONAL INFORMATION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH ADDITIONAL INFORMATION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * ADDITIONAL INFORMATION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH ADDITIONAL INFORMATION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * ADDITIONAL INFORMATION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH ADDITIONAL INFORMATION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * THE SARS-COV-2 SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * THE SARS-COV-2 SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH THE SARS-COV-2 SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH THE SARS-COV-2 SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * THE SARS-COV-2 SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH THE SARS-COV-2 SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * THE SARS-COV-2 SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH THE SARS-COV-2 SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * CDC’S OFFICE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * CDC’S OFFICE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH CDC’S OFFICE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH CDC’S OFFICE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * CDC’S OFFICE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH CDC’S OFFICE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * CDC’S OFFICE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH CDC’S OFFICE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * ADVANCED MOLECULAR DETECTION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * ADVANCED MOLECULAR DETECTION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH ADVANCED MOLECULAR DETECTION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH ADVANCED MOLECULAR DETECTION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * ADVANCED MOLECULAR DETECTION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH ADVANCED MOLECULAR DETECTION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * ADVANCED MOLECULAR DETECTION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH ADVANCED MOLECULAR DETECTION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * INFORMATION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * INFORMATION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH INFORMATION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH INFORMATION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * INFORMATION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH INFORMATION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * INFORMATION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH INFORMATION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * LABORATORIES *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * LABORATORIES *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH LABORATORIES *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH LABORATORIES</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * LABORATORIES</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH LABORATORIES *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * LABORATORIES</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH LABORATORIES</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * COVID-19 PRESS RELEASE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * COVID-19 PRESS RELEASE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH COVID-19 PRESS RELEASE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH COVID-19 PRESS RELEASE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * COVID-19 PRESS RELEASE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH COVID-19 PRESS RELEASE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * COVID-19 PRESS RELEASE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH COVID-19 PRESS RELEASE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * CDC *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * CDC *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH CDC *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH CDC</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * CDC</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH CDC *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * CDC</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH CDC</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * NATIONAL VIRAL GENOMICS CONSORTIUM *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * NATIONAL VIRAL GENOMICS CONSORTIUM *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH NATIONAL VIRAL GENOMICS CONSORTIUM *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH NATIONAL VIRAL GENOMICS CONSORTIUM</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * NATIONAL VIRAL GENOMICS CONSORTIUM</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH NATIONAL VIRAL GENOMICS CONSORTIUM *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * NATIONAL VIRAL GENOMICS CONSORTIUM</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH NATIONAL VIRAL GENOMICS CONSORTIUM</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * SARS-COV-2 TRANSMISSION NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * SARS-COV-2 TRANSMISSION NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH SARS-COV-2 TRANSMISSION NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH SARS-COV-2 TRANSMISSION NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * SARS-COV-2 TRANSMISSION NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH SARS-COV-2 TRANSMISSION NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * SARS-COV-2 TRANSMISSION NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH SARS-COV-2 TRANSMISSION NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * EMERGING AND ZOONOTIC INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * EMERGING AND ZOONOTIC INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH EMERGING AND ZOONOTIC INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH EMERGING AND ZOONOTIC INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * EMERGING AND ZOONOTIC INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH EMERGING AND ZOONOTIC INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * EMERGING AND ZOONOTIC INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH EMERGING AND ZOONOTIC INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * NCEZID *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * NCEZID *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH NCEZID *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH NCEZID</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * NCEZID</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH NCEZID *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * NCEZID</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH NCEZID</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * OFFICE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * OFFICE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH OFFICE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH OFFICE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * OFFICE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH OFFICE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * OFFICE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH OFFICE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * ADVANCED MOLECULAR DETECTION TESTING DATA *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * ADVANCED MOLECULAR DETECTION TESTING DATA *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH ADVANCED MOLECULAR DETECTION TESTING DATA *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH ADVANCED MOLECULAR DETECTION TESTING DATA</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * ADVANCED MOLECULAR DETECTION TESTING DATA</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH ADVANCED MOLECULAR DETECTION TESTING DATA *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * ADVANCED MOLECULAR DETECTION TESTING DATA</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH ADVANCED MOLECULAR DETECTION TESTING DATA</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * THE US SEROPREVALENCE SURVEYS *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * THE US SEROPREVALENCE SURVEYS *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH THE US SEROPREVALENCE SURVEYS *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH THE US SEROPREVALENCE SURVEYS</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * THE US SEROPREVALENCE SURVEYS</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH THE US SEROPREVALENCE SURVEYS *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * THE US SEROPREVALENCE SURVEYS</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH THE US SEROPREVALENCE SURVEYS</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * SPECIAL POPULATIONS *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * SPECIAL POPULATIONS *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH SPECIAL POPULATIONS *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH SPECIAL POPULATIONS</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * SPECIAL POPULATIONS</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH SPECIAL POPULATIONS *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * SPECIAL POPULATIONS</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH SPECIAL POPULATIONS</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * DEVELOPING GUIDANCE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * DEVELOPING GUIDANCE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH DEVELOPING GUIDANCE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH DEVELOPING GUIDANCE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * DEVELOPING GUIDANCE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH DEVELOPING GUIDANCE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * DEVELOPING GUIDANCE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH DEVELOPING GUIDANCE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * PUBLIC HEALTH *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * PUBLIC HEALTH *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH PUBLIC HEALTH *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH PUBLIC HEALTH</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH * PUBLIC HEALTH</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAUNCH PUBLIC HEALTH *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH * PUBLIC HEALTH</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAUNCH PUBLIC HEALTH</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MR. MOLERA *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MR. MOLERA *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MR. MOLERA</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MR. MOLERA</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ROUGHLY 70,000 RECENT LAW SCHOOL GRADUATES *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ROUGHLY 70,000 RECENT LAW SCHOOL GRADUATES *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ROUGHLY 70,000 RECENT LAW SCHOOL GRADUATES</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ROUGHLY 70,000 RECENT LAW SCHOOL GRADUATES</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WHO *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WHO *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WHO</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WHO</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE BAR *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE BAR *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE BAR</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE BAR</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THOUSANDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THOUSANDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THOUSANDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THOUSANDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHERS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHERS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHERS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHERS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LICENSING EXAMS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LICENSING EXAMS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LICENSING EXAMS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LICENSING EXAMS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SOCIAL WORK *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SOCIAL WORK *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SOCIAL WORK</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SOCIAL WORK</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENGINEERING *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENGINEERING *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENGINEERING</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENGINEERING</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURGERY *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURGERY *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURGERY</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURGERY</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER FIELDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER FIELDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER FIELDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER FIELDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HUNDREDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HUNDREDS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HUNDREDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HUNDREDS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER STUDENTS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER STUDENTS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER STUDENTS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER STUDENTS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CROWDED ROOMS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CROWDED ROOMS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CROWDED ROOMS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CROWDED ROOMS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UNIVERSITIES *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UNIVERSITIES *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UNIVERSITIES</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UNIVERSITIES</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TESTING CENTERS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TESTING CENTERS *</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TESTING CENTERS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TESTING CENTERS</pattern>
			<template>
				<random>
					<li>Mr. Molera, 25, is among roughly 70,000 recent law school graduates who take the bar each year, along with thousands of others who sit for licensing exams in social work, engineering, surgery and other fields, typically alongside hundreds of other students squeezed into crowded rooms at universities or testing centers.</li>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THOSE EXAMS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THOSE EXAMS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THOSE EXAMS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THOSE EXAMS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TESTING SITES *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TESTING SITES *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TESTING SITES</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TESTING SITES</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE SPRING *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE SPRING *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE SPRING</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE SPRING</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE CORONAVIRUS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE CORONAVIRUS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COUNTRY *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COUNTRY *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COUNTRY</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COUNTRY</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECENT GRADUATES *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECENT GRADUATES *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECENT GRADUATES</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECENT GRADUATES</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE START *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE START *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE START</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE START</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THEIR CAREERS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THEIR CAREERS *</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THEIR CAREERS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THEIR CAREERS</pattern>
			<template>
				<random>
					<li>Many of those exams were postponed and testing sites shut down in the spring as the coronavirus spread across the country, forcing recent graduates to delay the start of their careers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER STATES *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER STATES *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER STATES</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER STATES</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THEM *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THEM *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THEM</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THEM</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PERSON *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PERSON *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PERSON</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PERSON</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONCERN *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONCERN *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONCERN</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONCERN</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE POSSIBLE SPREAD *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE POSSIBLE SPREAD *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE POSSIBLE SPREAD</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE POSSIBLE SPREAD</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE VIRUS *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE VIRUS *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE VIRUS</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE VIRUS</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE ONE *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE ONE *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE ONE</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE ONE</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HIS EXAM *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HIS EXAM *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HIS EXAM</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HIS EXAM</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE UNIVERSITY *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE UNIVERSITY *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE UNIVERSITY</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE UNIVERSITY</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DENVER *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DENVER *</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DENVER</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DENVER</pattern>
			<template>
				<random>
					<li>Other states continued to offer them in person, raising concern about the possible spread of the virus at testing centers like the one where Mr. Molera took his exam at the University of Denver.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE CHAOS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE CHAOS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE CHAOS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE CHAOS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONFUSION *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONFUSION *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CONFUSION</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CONFUSION</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FUEL EFFORTS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FUEL EFFORTS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FUEL EFFORTS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FUEL EFFORTS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SOME STATES *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SOME STATES *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SOME STATES</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SOME STATES</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER LICENSING EXAMS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER LICENSING EXAMS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER LICENSING EXAMS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER LICENSING EXAMS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SOME CRITICS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SOME CRITICS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SOME CRITICS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SOME CRITICS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADMINISTRATORS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADMINISTRATORS *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADMINISTRATORS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADMINISTRATORS</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A NEEDED PROTECTION *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A NEEDED PROTECTION *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A NEEDED PROTECTION</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A NEEDED PROTECTION</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE PUBLIC *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE PUBLIC *</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE PUBLIC</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE PUBLIC</pattern>
			<template>
				<random>
					<li>The chaos and confusion are helping fuel efforts in some states to eliminate the bar and other licensing exams, which are seen by some critics as unnecessary and antiquated, while administrators defend them as a needed protection for the public.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* 23 STATES *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>23 STATES *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* 23 STATES</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>23 STATES</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* JULY *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>JULY *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* JULY</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>JULY</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE FALL *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE FALL *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE FALL</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE FALL</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SOME OFFERING *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SOME OFFERING *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SOME OFFERING</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SOME OFFERING</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A NEW REMOTE OPTION *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A NEW REMOTE OPTION *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A NEW REMOTE OPTION</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A NEW REMOTE OPTION</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OCTOBER *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OCTOBER *</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OCTOBER</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OCTOBER</pattern>
			<template>
				<random>
					<li>This year, 23 states went ahead with in-person exams in July, while at least 20 postponed them until the fall — with some offering a new remote option in October.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TESTING DATA *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TESTING DATA *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TESTING DATA</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TESTING DATA</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE US *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE US *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE US</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE US</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FAIR ACCESS *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FAIR ACCESS *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FAIR ACCESS</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FAIR ACCESS</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH HEALTH EQUITY *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH HEALTH EQUITY *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH HEALTH EQUITY</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH HEALTH EQUITY</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EVERYONE *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EVERYONE *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EVERYONE</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EVERYONE</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE OPPORTUNITY *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE OPPORTUNITY *</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE OPPORTUNITY</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE OPPORTUNITY</pattern>
			<template>
				<random>
					<li>Testing Data in the US Promoting Fair Access to Health Health equity is when everyone has the opportunity to be as healthy as possible.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LONG-STANDING SYSTEMIC HEALTH AND SOCIAL INEQUITIES *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LONG-STANDING SYSTEMIC HEALTH AND SOCIAL INEQUITIES *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LONG-STANDING SYSTEMIC HEALTH AND SOCIAL INEQUITIES</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LONG-STANDING SYSTEMIC HEALTH AND SOCIAL INEQUITIES</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MANY RACIAL AND ETHNIC MINORITY GROUPS *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MANY RACIAL AND ETHNIC MINORITY GROUPS *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MANY RACIAL AND ETHNIC MINORITY GROUPS</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MANY RACIAL AND ETHNIC MINORITY GROUPS</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCREASED RISK *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCREASED RISK *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INCREASED RISK</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INCREASED RISK</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 *</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19</pattern>
			<template>
				<random>
					<li>Long-standing systemic health and social inequities have put many racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19.</li>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE SPREAD *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE SPREAD *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE SPREAD</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE SPREAD</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GREATER HEALTH EQUITY *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GREATER HEALTH EQUITY *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GREATER HEALTH EQUITY</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GREATER HEALTH EQUITY</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WE *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WE *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WE</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WE</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESOURCES *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESOURCES *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESOURCES</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESOURCES</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PHYSICAL AND MENTAL HEALTH *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PHYSICAL AND MENTAL HEALTH *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PHYSICAL AND MENTAL HEALTH</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PHYSICAL AND MENTAL HEALTH</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EASY ACCESS *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EASY ACCESS *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EASY ACCESS</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EASY ACCESS</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INFORMATION *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INFORMATION *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INFORMATION</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INFORMATION</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AFFORDABLE TESTING *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AFFORDABLE TESTING *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AFFORDABLE TESTING</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AFFORDABLE TESTING</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MEDICAL AND MENTAL HEALTH CARE *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MEDICAL AND MENTAL HEALTH CARE *</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MEDICAL AND MENTAL HEALTH CARE</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MEDICAL AND MENTAL HEALTH CARE</pattern>
			<template>
				<random>
					<li>To stop the spread of COVID-19 and move toward greater health equity, we must work together to ensure resources are available to maintain and manage physical and mental health, including easy access to information, affordable testing, and medical and mental health care.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WHAT *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WHAT *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WHAT</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WHAT</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH EQUITY CDC COVID-19 RESPONSE HEALTH EQUITY STRATEGY NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH EQUITY CDC COVID-19 RESPONSE HEALTH EQUITY STRATEGY NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH EQUITY CDC COVID-19 RESPONSE HEALTH EQUITY STRATEGY NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH EQUITY CDC COVID-19 RESPONSE HEALTH EQUITY STRATEGY NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IMMUNIZATION *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IMMUNIZATION *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IMMUNIZATION</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IMMUNIZATION</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESPIRATORY DISEASES *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESPIRATORY DISEASES *</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESPIRATORY DISEASES</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESPIRATORY DISEASES</pattern>
			<template>
				<random>
					<li>What We Can Do to Promote Health Equity CDC COVID-19 Response Health Equity Strategy National Center for Immunization and Respiratory Diseases (NCIRD)</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CDC *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CDC *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CDC</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CDC</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS CRITICAL WORK *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS CRITICAL WORK *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS CRITICAL WORK</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS CRITICAL WORK</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LONG-TERM CARE AND NURSING HOMES CONTENT *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LONG-TERM CARE AND NURSING HOMES CONTENT *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LONG-TERM CARE AND NURSING HOMES CONTENT</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LONG-TERM CARE AND NURSING HOMES CONTENT</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NON-CDC TOOLS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NON-CDC TOOLS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NON-CDC TOOLS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NON-CDC TOOLS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS SITE *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS SITE *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS SITE</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS SITE</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INFORMATIONAL PURPOSES *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INFORMATIONAL PURPOSES *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INFORMATIONAL PURPOSES</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INFORMATIONAL PURPOSES</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENDORSEMENT *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENDORSEMENT *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ENDORSEMENT</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ENDORSEMENT</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE TOOLS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE TOOLS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE TOOLS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE TOOLS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing guidance for: Long-term Care and Nursing Homes Content describing non-CDC tools on this site is provided for informational purposes only and is not intended to indicate endorsement , actual or implied, of the tools.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USERS *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USERS *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* USERS</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>USERS</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THEIR OWN DETERMINATION *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THEIR OWN DETERMINATION *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THEIR OWN DETERMINATION</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THEIR OWN DETERMINATION</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THEIR EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THEIR EFFECTIVENESS *</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THEIR EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THEIR EFFECTIVENESS</pattern>
			<template>
				<random>
					<li>Additionally, information on this site is provided “as is,” for users to evaluate and make their own determination as to their effectiveness.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEVERAL OTHER FEDERAL AGENCIES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEVERAL OTHER FEDERAL AGENCIES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEVERAL OTHER FEDERAL AGENCIES</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEVERAL OTHER FEDERAL AGENCIES</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS CRITICAL EFFORT *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS CRITICAL EFFORT *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS CRITICAL EFFORT</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS CRITICAL EFFORT</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION LIST *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION LIST *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION LIST</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION LIST</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORKERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORKERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* WORKERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>WORKERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EMPLOYERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EMPLOYERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EMPLOYERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EMPLOYERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DIVERSE FIELDS/SETTINGS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DIVERSE FIELDS/SETTINGS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DIVERSE FIELDS/SETTINGS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DIVERSE FIELDS/SETTINGS</pattern>
			<template>
				<random>
					<li>Several other federal agencies are also supporting this critical effort by providing resources: Occupational Safety and Health Administration List of resources and guidance for workers and employers in diverse fields/settings</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* VARIOUS OTHER ORGANIZATIONS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>VARIOUS OTHER ORGANIZATIONS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* VARIOUS OTHER ORGANIZATIONS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>VARIOUS OTHER ORGANIZATIONS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TRAINING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TRAINING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TRAINING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TRAINING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER RESOURCES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER RESOURCES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER RESOURCES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER RESOURCES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing training and other resources:</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AMERICAN COLLEGE *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AMERICAN COLLEGE *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AMERICAN COLLEGE</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AMERICAN COLLEGE</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EMERGENCY PHYSICIANS COVID-19 FIELD *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EMERGENCY PHYSICIANS COVID-19 FIELD *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EMERGENCY PHYSICIANS COVID-19 FIELD</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EMERGENCY PHYSICIANS COVID-19 FIELD</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AMERICAN ACADEMY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AMERICAN ACADEMY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AMERICAN ACADEMY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AMERICAN ACADEMY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PEDIATRICS TELEHEALTH PAYER POLICY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PEDIATRICS TELEHEALTH PAYER POLICY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PEDIATRICS TELEHEALTH PAYER POLICY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PEDIATRICS TELEHEALTH PAYER POLICY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESPONSE *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESPONSE *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESPONSE</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESPONSE</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 SOCIETY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 SOCIETY *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 SOCIETY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 SOCIETY</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CRITICAL *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CRITICAL *</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CRITICAL</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CRITICAL</pattern>
			<template>
				<random>
					<li>American College of Emergency Physicians COVID-19 Field guide American Academy of Pediatrics Telehealth Payer Policy in Response to COVID-19 Society for Critical</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 RESOURCE CENTER *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 RESOURCE CENTER *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 RESOURCE CENTER</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 RESOURCE CENTER</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LITERATURE *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LITERATURE *</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LITERATURE</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LITERATURE</pattern>
			<template>
				<random>
					<li>COVID-19 Resource Center Includes literature and training.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PAGES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PAGES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PAGES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PAGES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE LANGUAGE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE LANGUAGE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE LANGUAGE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE LANGUAGE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* YOU *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>YOU *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* YOU</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>YOU</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESULT URLS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESULT URLS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESULT URLS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESULT URLS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS TERM *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS TERM *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS TERM</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS TERM</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESULTS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESULTS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESULTS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESULTS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THESE GIVEN DATES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THESE GIVEN DATES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THESE GIVEN DATES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THESE GIVEN DATES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE US CONTACT TRACING RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE US CONTACT TRACING RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE US CONTACT TRACING RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE US CONTACT TRACING RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH DEPARTMENTS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH DEPARTMENTS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CASES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CASES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CASES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CASES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HOMELESS SHELTERS TOOLKIT *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HOMELESS SHELTERS TOOLKIT *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HOMELESS SHELTERS TOOLKIT</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HOMELESS SHELTERS TOOLKIT</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STATE PUBLIC HEALTH VETERINARIANS DISASTER SHELTERING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STATE PUBLIC HEALTH VETERINARIANS DISASTER SHELTERING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STATE PUBLIC HEALTH VETERINARIANS DISASTER SHELTERING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STATE PUBLIC HEALTH VETERINARIANS DISASTER SHELTERING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HOUSEHOLD PETS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HOUSEHOLD PETS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HOUSEHOLD PETS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HOUSEHOLD PETS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SERVICE ANIMALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SERVICE ANIMALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SERVICE ANIMALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SERVICE ANIMALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT ANIMALS COMMUNICATION RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT ANIMALS COMMUNICATION RESOURCES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUPPORT ANIMALS COMMUNICATION RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUPPORT ANIMALS COMMUNICATION RESOURCES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH DEPARTMENTS GUIDANCE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH DEPARTMENTS GUIDANCE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH DEPARTMENTS GUIDANCE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH DEPARTMENTS GUIDANCE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COMMUNITY VIRAL TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COMMUNITY VIRAL TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COMMUNITY VIRAL TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COMMUNITY VIRAL TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ANTIBODY TESTING INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ANTIBODY TESTING INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ANTIBODY TESTING INDIVIDUALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ANTIBODY TESTING INDIVIDUALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SYMPTOMS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SYMPTOMS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SYMPTOMS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SYMPTOMS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECENT EXPOSURE INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECENT EXPOSURE INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECENT EXPOSURE INDIVIDUALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECENT EXPOSURE INDIVIDUALS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EXPOSURE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EXPOSURE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EXPOSURE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EXPOSURE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SPECIAL SETTINGS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SPECIAL SETTINGS *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SPECIAL SETTINGS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SPECIAL SETTINGS</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BROAD-BASED VIRAL TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BROAD-BASED VIRAL TESTING *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BROAD-BASED VIRAL TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BROAD-BASED VIRAL TESTING</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FACILITIES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FACILITIES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FACILITIES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FACILITIES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* KNOWN OR SUSPECTED SARS-COV-2 EXPOSURE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>KNOWN OR SUSPECTED SARS-COV-2 EXPOSURE *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* KNOWN OR SUSPECTED SARS-COV-2 EXPOSURE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>KNOWN OR SUSPECTED SARS-COV-2 EXPOSURE</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUBSTANTIAL TRANSMISSION *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUBSTANTIAL TRANSMISSION *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUBSTANTIAL TRANSMISSION</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUBSTANTIAL TRANSMISSION</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COMMUNITY *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COMMUNITY *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COMMUNITY</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COMMUNITY</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance for Health Departments about COVID-19 Testing in the Community Viral Testing and Antibody Testing Individuals without Symptoms and Recent Exposure Individuals without Exposure in Special Settings Prepare for broad-based viral testing in facilities after known or suspected SARS-CoV-2 exposure or when there is moderate to substantial transmission in the community.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A FORM *</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A FORM *</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A FORM</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A FORM</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A STANDARDIZED APPROACH *</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A STANDARDIZED APPROACH *</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A STANDARDIZED APPROACH</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A STANDARDIZED APPROACH</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 CASES *</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 CASES *</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 CASES</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 CASES</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* (INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>(INDIVIDUALS *</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* (INDIVIDUALS</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>(INDIVIDUALS</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AT LEAST ONE RESPIRATORY SPECIMEN *</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AT LEAST ONE RESPIRATORY SPECIMEN *</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AT LEAST ONE RESPIRATORY SPECIMEN</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AT LEAST ONE RESPIRATORY SPECIMEN</pattern>
			<template>
				<random>
					<li>CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A COMBINATION *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A COMBINATION *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A COMBINATION</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A COMBINATION</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DATA SOURCES *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DATA SOURCES *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DATA SOURCES</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DATA SOURCES</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EXISTING INFLUENZA *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EXISTING INFLUENZA *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EXISTING INFLUENZA</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EXISTING INFLUENZA</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* VIRAL RESPIRATORY DISEASE SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>VIRAL RESPIRATORY DISEASE SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* VIRAL RESPIRATORY DISEASE SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>VIRAL RESPIRATORY DISEASE SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SYNDROMIC SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SYNDROMIC SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SYNDROMIC SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SYNDROMIC SURVEILLANCE</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CASE REPORTING *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CASE REPORTING *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CASE REPORTING</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CASE REPORTING</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COMMERCIAL LAB REPORTING *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COMMERCIAL LAB REPORTING *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COMMERCIAL LAB REPORTING</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COMMERCIAL LAB REPORTING</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ONGOING RESEARCH PLATFORMS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ONGOING RESEARCH PLATFORMS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ONGOING RESEARCH PLATFORMS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ONGOING RESEARCH PLATFORMS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER NEW SYSTEMS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER NEW SYSTEMS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER NEW SYSTEMS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER NEW SYSTEMS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SPECIFIC QUESTIONS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SPECIFIC QUESTIONS *</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SPECIFIC QUESTIONS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SPECIFIC QUESTIONS</pattern>
			<template>
				<random>
					<li>COVID-19 surveillance draws from a combination of data sources from existing influenza and viral respiratory disease surveillance, syndromic surveillance, case reporting, commercial lab reporting, ongoing research platforms, and other new systems designed to answer specific questions.</li>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AN UPDATED, ACCURATE PICTURE *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AN UPDATED, ACCURATE PICTURE *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AN UPDATED, ACCURATE PICTURE</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AN UPDATED, ACCURATE PICTURE</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SARS-COV-2 SPREAD *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SARS-COV-2 SPREAD *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SARS-COV-2 SPREAD</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SARS-COV-2 SPREAD</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ITS EFFECTS *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ITS EFFECTS *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ITS EFFECTS</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ITS EFFECTS</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE UNITED STATES *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE UNITED STATES</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE UNITED STATES</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DATA *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DATA *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DATA</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DATA</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE U. S. NATIONAL PUBLIC HEALTH RESPONSE *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE U. S. NATIONAL PUBLIC HEALTH RESPONSE *</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE U. S. NATIONAL PUBLIC HEALTH RESPONSE</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE U. S. NATIONAL PUBLIC HEALTH RESPONSE</pattern>
			<template>
				<random>
					<li>other new systems designed to answer specific questions create an updated, accurate picture of SARS-COV-2 spread and its effects in the United States and provide data used to inform the U. S. national public health response to COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SURVEILLANCE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SURVEILLANCE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 AND COVID-19 CAUSE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 AND COVID-19 CAUSE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 AND COVID-19 CAUSE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 AND COVID-19 CAUSE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SARS-COV-2 *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SARS-COV-2 *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SARS-COV-2</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SARS-COV-2</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MULTIPLE SURVEILLANCE SYSTEMS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MULTIPLE SURVEILLANCE SYSTEMS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MULTIPLE SURVEILLANCE SYSTEMS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MULTIPLE SURVEILLANCE SYSTEMS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COLLABORATION *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COLLABORATION *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COLLABORATION</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COLLABORATION</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STATE, LOCAL AND TERRITORIAL HEALTH DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STATE, LOCAL AND TERRITORIAL HEALTH DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STATE, LOCAL AND TERRITORIAL HEALTH DEPARTMENTS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STATE, LOCAL AND TERRITORIAL HEALTH DEPARTMENTS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COMMERCIAL AND CLINICAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COMMERCIAL AND CLINICAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COMMERCIAL AND CLINICAL LABORATORIES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COMMERCIAL AND CLINICAL LABORATORIES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* VITAL STATISTICS OFFICES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>VITAL STATISTICS OFFICES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* VITAL STATISTICS OFFICES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>VITAL STATISTICS OFFICES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH CARE PROVIDERS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH CARE PROVIDERS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH CARE PROVIDERS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH CARE PROVIDERS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EMERGENCY DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EMERGENCY DEPARTMENTS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EMERGENCY DEPARTMENTS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EMERGENCY DEPARTMENTS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACADEMIC PARTNERS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACADEMIC PARTNERS *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACADEMIC PARTNERS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACADEMIC PARTNERS</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 DISEASE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 DISEASE *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 DISEASE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 DISEASE</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE UNITED SCDCES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE UNITED SCDCES *</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE UNITED SCDCES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE UNITED SCDCES</pattern>
			<template>
				<random>
					<li>For surveillance of COVID-19 and COVID-19 cause, SARS-CoV-2, in the United States, CDC is using multiple surveillance systems run in collaboration with state, local and territorial health departments, public health, commercial and clinical laboratories, vital statistics offices, health care providers, emergency departments and academic partners to monitor COVID-19 disease in the United SCDCes.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A WEEKLY SUMMARY *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A WEEKLY SUMMARY *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A WEEKLY SUMMARY</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A WEEKLY SUMMARY</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INTERPRETATION *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INTERPRETATION *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INTERPRETATION</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INTERPRETATION</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* KEY INDICATORS *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>KEY INDICATORS *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* KEY INDICATORS</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>KEY INDICATORS</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COVID-19 PANDEMIC *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COVID-19 PANDEMIC *</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COVID-19 PANDEMIC</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COVID-19 PANDEMIC</pattern>
			<template>
				<random>
					<li>CDC provides a weekly summary and interpretation of key indicators that have been adapted to track the COVID-19 pandemic in the United States.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAB-CONFIRMED COVID-19 HOSPITALIZATIONS *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAB-CONFIRMED COVID-19 HOSPITALIZATIONS *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LAB-CONFIRMED COVID-19 HOSPITALIZATIONS</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LAB-CONFIRMED COVID-19 HOSPITALIZATIONS</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RISK FACTORS *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RISK FACTORS *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RISK FACTORS</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RISK FACTORS</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OUTCOMES *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OUTCOMES *</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OUTCOMES</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OUTCOMES</pattern>
			<template>
				<random>
					<li>CDC monitors lab-confirmed COVID-19 hospitalizations, risk factors, and outcomes of those hospitalized each week.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVISIONAL DEATH COUNTS *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVISIONAL DEATH COUNTS *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROVISIONAL DEATH COUNTS</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROVISIONAL DEATH COUNTS</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PNEUMONIA *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PNEUMONIA *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PNEUMONIA</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PNEUMONIA</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEATH CERTIFICATES *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEATH CERTIFICATES *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEATH CERTIFICATES</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEATH CERTIFICATES</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATES *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATES *</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPDATES</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPDATES</pattern>
			<template>
				<random>
					<li>CDC provides provisional death counts for COVID-19 and pneumonia based on death certificates with updates Monday-Friday.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FURTHER SPREAD *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FURTHER SPREAD *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FURTHER SPREAD</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FURTHER SPREAD</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SARS-COV-2 IMPACT *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SARS-COV-2 IMPACT *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SARS-COV-2 IMPACT</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SARS-COV-2 IMPACT</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH OUTCOMES *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH OUTCOMES *</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH OUTCOMES</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH OUTCOMES</pattern>
			<template>
				<random>
					<li>To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and SARS-CoV-2 impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COVID-19 DATA INTEROPERABILITY STANDARDS *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COVID-19 DATA INTEROPERABILITY STANDARDS *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COVID-19 DATA INTEROPERABILITY STANDARDS</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COVID-19 DATA INTEROPERABILITY STANDARDS</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* REGULATIONS REPOSITORY *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>REGULATIONS REPOSITORY *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* REGULATIONS REPOSITORY</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>REGULATIONS REPOSITORY</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COMMUNICATION *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COMMUNICATION *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COMMUNICATION</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COMMUNICATION</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARD DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARD DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARD DEVELOPMENT</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARD DEVELOPMENT</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARD IMPLEMENTATION ORGANIZATIONS *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARD IMPLEMENTATION ORGANIZATIONS *</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARD IMPLEMENTATION ORGANIZATIONS</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARD IMPLEMENTATION ORGANIZATIONS</pattern>
			<template>
				<random>
					<li>CDC develops and maintains the COVID-19 data interoperability standards and regulations repository that is based on communication and collaboration with standard development and standard implementation organizations.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STATE AND TERRITORIAL PUBLIC HEALTH PARTNERS *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STATE AND TERRITORIAL PUBLIC HEALTH PARTNERS *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STATE AND TERRITORIAL PUBLIC HEALTH PARTNERS</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STATE AND TERRITORIAL PUBLIC HEALTH PARTNERS</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 CASE *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 CASE *</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 CASE</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 CASE</pattern>
			<template>
				<random>
					<li>National COVID-19 reporting: CDC works with state and territorial public health partners to coordinate COVID-19 case reporting nationally.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COVID-19 CASE DEFINITION *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COVID-19 CASE DEFINITION *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COVID-19 CASE DEFINITION</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COVID-19 CASE DEFINITION</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COUNCIL *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COUNCIL *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COUNCIL</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COUNCIL</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STATE AND TERRITORIAL EPIDEMIOLOGISTS *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STATE AND TERRITORIAL EPIDEMIOLOGISTS *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STATE AND TERRITORIAL EPIDEMIOLOGISTS</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STATE AND TERRITORIAL EPIDEMIOLOGISTS</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CSTE *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CSTE *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CSTE</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CSTE</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* APRIL *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>APRIL *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* APRIL</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>APRIL</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AN INTERIM COVID-19 POSITION STATEMENT *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AN INTERIM COVID-19 POSITION STATEMENT *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AN INTERIM COVID-19 POSITION STATEMENT</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AN INTERIM COVID-19 POSITION STATEMENT</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A CASE DEFINITION *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A CASE DEFINITION *</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A CASE DEFINITION</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A CASE DEFINITION</pattern>
			<template>
				<random>
					<li>The COVID-19 case definition is standardized with the Council of State and Territorial Epidemiologists (CSTE), which issued on April 5, 2020 an interim COVID-19 position statement that includes a case definition and made COVID-19 a nationally notifiable disease.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ITS IMPACT *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ITS IMPACT *</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ITS IMPACT</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ITS IMPACT</pattern>
			<template>
				<random>
					<li>To better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CASE-BASED SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CASE-BASED SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CASE-BASED SURVEILLANCE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CASE-BASED SURVEILLANCE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MECHANISMS *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MECHANISMS *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MECHANISMS</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MECHANISMS</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CASE DATA *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CASE DATA *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CASE DATA</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CASE DATA</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SHARE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SHARE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SHARE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SHARE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CDC PARTNERS *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CDC PARTNERS *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CDC PARTNERS</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CDC PARTNERS</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TECHNICAL ASSISTANCE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TECHNICAL ASSISTANCE *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TECHNICAL ASSISTANCE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TECHNICAL ASSISTANCE</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NEW HL7 MESSAGE MAPPING GUIDES *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NEW HL7 MESSAGE MAPPING GUIDES *</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NEW HL7 MESSAGE MAPPING GUIDES</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NEW HL7 MESSAGE MAPPING GUIDES</pattern>
			<template>
				<random>
					<li>Case-based surveillance (which includes mechanisms to securely receive case data and share with CDC partners and technical assistance with onboarding new HL7 message mapping guides).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NATIONAL SYNDROMIC SURVEILLANCE PROGRAM *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NATIONAL SYNDROMIC SURVEILLANCE PROGRAM *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NATIONAL SYNDROMIC SURVEILLANCE PROGRAM</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NATIONAL SYNDROMIC SURVEILLANCE PROGRAM</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NSSP *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NSSP *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NSSP</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NSSP</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ONBOARDED FACILITIES *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ONBOARDED FACILITIES *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ONBOARDED FACILITIES</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ONBOARDED FACILITIES</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 TEST ORDERS *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 TEST ORDERS *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 TEST ORDERS</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 TEST ORDERS</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* 6 MAJOR COMMERCIAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>6 MAJOR COMMERCIAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* 6 MAJOR COMMERCIAL LABORATORIES</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>6 MAJOR COMMERCIAL LABORATORIES</pattern>
			<template>
				<random>
					<li>National Syndromic Surveillance Program (NSSP) Includes Emergency Department visits for onboarded facilities and COVID-19 test orders and results for 6 major commercial laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* QUALITY-CONTROLLED LINE-LEVEL DATA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>QUALITY-CONTROLLED LINE-LEVEL DATA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* QUALITY-CONTROLLED LINE-LEVEL DATA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>QUALITY-CONTROLLED LINE-LEVEL DATA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ED VISITS *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ED VISITS *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ED VISITS</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ED VISITS</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19—INCLUDING PCR *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19—INCLUDING PCR *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19—INCLUDING PCR</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19—INCLUDING PCR</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NOW IGA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NOW IGA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NOW IGA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NOW IGA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IGG *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IGG *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IGG</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IGG</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IGM *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IGM *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IGM</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IGM</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESSENCE *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESSENCE *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ESSENCE</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ESSENCE</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADVANCED TOOLS *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADVANCED TOOLS *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADVANCED TOOLS</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADVANCED TOOLS</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THESE DATA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THESE DATA *</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THESE DATA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THESE DATA</pattern>
			<template>
				<random>
					<li>For quality-controlled line-level data for ED visits and 6 major commercial labs testing for COVID-19—including PCR and as of now IgA, IgG, and IgM as well; ESSENCE also provides advanced tools to rapidly query, visualize and analyze these data).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INSIGHTS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INSIGHTS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INSIGHTS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INSIGHTS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POLICIES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POLICIES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POLICIES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POLICIES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Aim to provide insights into what has changed in response to policies aimed at combating COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EMAIL UPDATES *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EMAIL UPDATES *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EMAIL UPDATES</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EMAIL UPDATES</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* YOUR EMAIL ADDRESS *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>YOUR EMAIL ADDRESS *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* YOUR EMAIL ADDRESS</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>YOUR EMAIL ADDRESS</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LINKS *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LINKS *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LINKS</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LINKS</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS ICON *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS ICON *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS ICON</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS ICON</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE CDC WEBSITE *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE CDC WEBSITE *</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE CDC WEBSITE</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE CDC WEBSITE</pattern>
			<template>
				<random>
					<li>To receive email updates about COVID-19, enter your email address: Links with this icon indicate that you are leaving the CDC website.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LABORATORIES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LABORATORIES *</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LABORATORIES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LABORATORIES</pattern>
			<template>
				<random>
					<li>Find pages in the language you select Result URLs must contain this term Results updated between these given dates Testing Data in the US Contact Tracing Resources for Health Departments Investigating Cases in Homeless Shelters Toolkit for State Public Health Veterinarians Disaster Sheltering of Household Pets, Service Animals, &amp; Support Animals Communication Resources for Health Departments Guidance and Resources for Laboratories</li>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE DEPARTMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE DEPARTMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HUMAN SERVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HUMAN SERVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HUMAN SERVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HUMAN SERVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HHS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HHS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HHS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HHS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE U. S. GOVERNMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE U. S. GOVERNMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE U. S. GOVERNMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE U. S. GOVERNMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEFENSE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEFENSE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEFENSE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEFENSE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POTENTIAL PRODUCTS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POTENTIAL PRODUCTS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POTENTIAL PRODUCTS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POTENTIAL PRODUCTS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC AND PRIVATE SECTORS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC AND PRIVATE SECTORS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC AND PRIVATE SECTORS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC AND PRIVATE SECTORS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROMISING CANDIDATES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROMISING CANDIDATES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROMISING CANDIDATES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROMISING CANDIDATES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOPMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOPMENT</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LICENSURE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LICENSURE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LICENSURE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LICENSURE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) works across the U. S. government, including with the Department of Defense, to review potential products from public and private sectors to identify promising candidates that could detect, protect against or treat COVID-19 for development and licensure.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CARE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CARE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CARE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CARE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVICES *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVICES</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH LABS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH LABS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH LABS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH LABS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PHLS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PHLS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PHLS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PHLS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EVERY STATE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EVERY STATE *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EVERY STATE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EVERY STATE</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TERRITORY *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TERRITORY *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TERRITORY</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TERRITORY</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* D. C. FDA *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>D. C. FDA *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* D. C. FDA</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>D. C. FDA</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EMERGENCY USE AUTHORIZATIONS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EMERGENCY USE AUTHORIZATIONS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EMERGENCY USE AUTHORIZATIONS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EMERGENCY USE AUTHORIZATIONS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 TESTS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 TESTS *</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 TESTS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 TESTS</pattern>
			<template>
				<random>
					<li>The Department of Health and Human Services (HHS) is providing rapid point-of-care tests and devices to public health labs (PHLs) in every state and territory, and Washington, D. C. FDA issues emergency use authorizations for COVID-19 tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* D. C. D. C. FDA *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>D. C. D. C. FDA *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* D. C. D. C. FDA</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>D. C. D. C. FDA</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEVERAL EMERGENCY USE AUTHORIZATIONS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEVERAL EMERGENCY USE AUTHORIZATIONS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEVERAL EMERGENCY USE AUTHORIZATIONS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEVERAL EMERGENCY USE AUTHORIZATIONS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EUAS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EUAS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EUAS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EUAS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE USE *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE USE *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE USE</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE USE</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NEW VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NEW VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NEW VIRAL TESTS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NEW VIRAL TESTS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE SARS-COV-2 VIRUS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE SARS-COV-2 VIRUS *</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE SARS-COV-2 VIRUS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE SARS-COV-2 VIRUS</pattern>
			<template>
				<random>
					<li>D. C. D. C. FDA has issued several Emergency Use Authorizations (EUAs) for the use of new viral tests to detect the SARS-CoV-2 virus, which causes COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH EMERGENCIES *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH EMERGENCIES *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH EMERGENCIES</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH EMERGENCIES</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SECTION *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SECTION *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SECTION</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SECTION</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE FD&amp;C ACT *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE FD&amp;C ACT *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE FD&amp;C ACT</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE FD&amp;C ACT</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CERTAIN CRITERIA *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CERTAIN CRITERIA *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CERTAIN CRITERIA</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CERTAIN CRITERIA</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DISTRIBUTION *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DISTRIBUTION *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DISTRIBUTION</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DISTRIBUTION</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POTENTIALLY LIFE-SAVING MEDICAL PRODUCTS *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POTENTIALLY LIFE-SAVING MEDICAL PRODUCTS *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POTENTIALLY LIFE-SAVING MEDICAL PRODUCTS</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POTENTIALLY LIFE-SAVING MEDICAL PRODUCTS</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE DISEASE *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE DISEASE *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE DISEASE</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE DISEASE</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* VIRAL TESTS</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>VIRAL TESTS</pattern>
			<template>
				<random>
					<li>During public health emergencies declared under section 564 of the FD&amp;C Act, D. C. D. C. FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include viral tests.</li>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INTERIM GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INTERIM GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INTERIM GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INTERIM GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LABORATORY PROFESSIONALS *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LABORATORY PROFESSIONALS *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LABORATORY PROFESSIONALS</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LABORATORY PROFESSIONALS</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SPECIMENS *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SPECIMENS *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SPECIMENS</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SPECIMENS</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PERSONS *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PERSONS *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PERSONS</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PERSONS</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INVESTIGATION *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INVESTIGATION *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INVESTIGATION</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INVESTIGATION</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUI *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUI *</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUI</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUI</pattern>
			<template>
				<random>
					<li>CDC provides guidance and resources for laboratories CDC provides interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for COVID-19.</li>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ORDER *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ORDER *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ORDER</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ORDER</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH CARE WORKERS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH CARE WORKERS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HEALTH CARE WORKERS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HEALTH CARE WORKERS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LABORATORIANS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LABORATORIANS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LABORATORIANS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LABORATORIANS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LABORATORY BIOSAFETY GUIDELINES *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LABORATORY BIOSAFETY GUIDELINES *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LABORATORY BIOSAFETY GUIDELINES</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LABORATORY BIOSAFETY GUIDELINES</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HANDLING AND PROCESSING SPECIMENS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HANDLING AND PROCESSING SPECIMENS *</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HANDLING AND PROCESSING SPECIMENS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HANDLING AND PROCESSING SPECIMENS</pattern>
			<template>
				<random>
					<li>In order to protect health care workers and laboratorians, CDC provides laboratory biosafety guidelines for handling and processing specimens associated with COVID-19.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GENERAL GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GENERAL GUIDANCE *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GENERAL GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GENERAL GUIDANCE</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HANDLING *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HANDLING *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* HANDLING</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>HANDLING</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BULK-PACKAGED STERILE SWABS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BULK-PACKAGED STERILE SWABS *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BULK-PACKAGED STERILE SWABS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BULK-PACKAGED STERILE SWABS</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPPER RESPIRATORY SAMPLE COLLECTION *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPPER RESPIRATORY SAMPLE COLLECTION *</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* UPPER RESPIRATORY SAMPLE COLLECTION</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>UPPER RESPIRATORY SAMPLE COLLECTION</pattern>
			<template>
				<random>
					<li>CDC is supporting this critical work by providing: General Guidance for Handling Bulk-Packaged Sterile Swabs Properly for Upper Respiratory Sample Collection</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS PAGE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					<li>This page describes key CDC laboratory activities.</li>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS PAGE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					<li>This page describes key CDC laboratory activities.</li>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS PAGE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					<li>This page describes key CDC laboratory activities.</li>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS PAGE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					<li>This page describes key CDC laboratory activities.</li>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CORONAVIRUS *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CORONAVIRUS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CORONAVIRUS</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DISEASE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DISEASE *</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DISEASE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DISEASE</pattern>
			<template>
				<random>
					<li>This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE IRR *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE IRR *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE IRR</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE IRR</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* REAGENTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>REAGENTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* REAGENTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>REAGENTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SCIENTISTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SCIENTISTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SCIENTISTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SCIENTISTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BASIC RESEARCH *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BASIC RESEARCH *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BASIC RESEARCH</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BASIC RESEARCH</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IMPROVED VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IMPROVED VIRAL TESTS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IMPROVED VIRAL TESTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IMPROVED VIRAL TESTS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* VACCINES *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>VACCINES *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* VACCINES</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>VACCINES</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DETECTION METHODS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DETECTION METHODS *</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DETECTION METHODS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DETECTION METHODS</pattern>
			<template>
				<random>
					<li>The IRR acquires, authenticates, and produces reagents that scientists need to carry out basic research and develop improved viral tests, vaccines, and detection methods.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE FEDERAL EMERGENCY MANAGEMENT AGENCY *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE FEDERAL EMERGENCY MANAGEMENT AGENCY *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE FEDERAL EMERGENCY MANAGEMENT AGENCY</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE FEDERAL EMERGENCY MANAGEMENT AGENCY</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FEMA *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FEMA *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FEMA</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FEMA</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE PROCESS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE PROCESS *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE PROCESS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE PROCESS</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STATES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STATES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STATES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STATES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TERRITORIES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TERRITORIES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TERRITORIES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TERRITORIES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DIAGNOSTICS SUPPLIES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DIAGNOSTICS SUPPLIES *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DIAGNOSTICS SUPPLIES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DIAGNOSTICS SUPPLIES</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CHARGE *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CHARGE *</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CHARGE</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CHARGE</pattern>
			<template>
				<random>
					<li>The Federal Emergency Management Agency (FEMA) and HHS have simplified the process for states and territories to help public health labs access diagnostics supplies and reagents for COVID-19 testing free of charge through The IRR.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECOMMENDATIONS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECOMMENDATIONS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RECOMMENDATIONS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RECOMMENDATIONS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEROLOGIC TESTS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEROLOGIC TESTS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEROLOGIC TESTS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEROLOGIC TESTS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROTECTIVE IMMUNITY *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROTECTIVE IMMUNITY *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PROTECTIVE IMMUNITY</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PROTECTIVE IMMUNITY</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INFECTIOUSNESS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INFECTIOUSNESS *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INFECTIOUSNESS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INFECTIOUSNESS</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAR-COV-2 *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAR-COV-2 *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SAR-COV-2</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SAR-COV-2</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NEW INFORMATION *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NEW INFORMATION *</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NEW INFORMATION</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NEW INFORMATION</pattern>
			<template>
				<random>
					<li>Recommendations on the use of serologic tests to determine protective immunity and infectiousness among persons recently infected with SAR-CoV-2 will be updated as new information becomes available.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INTERIM GUIDELINES *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INTERIM GUIDELINES *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INTERIM GUIDELINES</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INTERIM GUIDELINES</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TESTING CLINICAL SPECIMENS *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TESTING CLINICAL SPECIMENS *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TESTING CLINICAL SPECIMENS</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TESTING CLINICAL SPECIMENS</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CORONAVIRUS DISEASE *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CORONAVIRUS DISEASE *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CORONAVIRUS DISEASE</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CORONAVIRUS DISEASE</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARD RECOMMENDED PROCEDURES *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARD RECOMMENDED PROCEDURES *</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARD RECOMMENDED PROCEDURES</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARD RECOMMENDED PROCEDURES</pattern>
			<template>
				<random>
					<li>Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 follow standard recommended procedures.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MORE INFORMATION *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MORE INFORMATION *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MORE INFORMATION</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MORE INFORMATION</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PRECAUTIONS *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PRECAUTIONS *</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PRECAUTIONS</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PRECAUTIONS</pattern>
			<template>
				<random>
					<li>Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TIMELY COMMUNICATION *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TIMELY COMMUNICATION *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TIMELY COMMUNICATION</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TIMELY COMMUNICATION</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CLINICAL AND LABORATORY STAFF *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CLINICAL AND LABORATORY STAFF *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CLINICAL AND LABORATORY STAFF</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CLINICAL AND LABORATORY STAFF</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE RISK *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE RISK *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE RISK</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE RISK</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PATIENTS *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PATIENTS *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PATIENTS</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PATIENTS</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSSIBLE SARS-COV-2 INFECTION *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSSIBLE SARS-COV-2 INFECTION *</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* POSSIBLE SARS-COV-2 INFECTION</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>POSSIBLE SARS-COV-2 INFECTION</pattern>
			<template>
				<random>
					<li>Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IT *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IT *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IT</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IT</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE NUMBER *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE NUMBER *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE NUMBER</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE NUMBER</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SARS *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SARS *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SARS</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SARS</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CDC LABS *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CDC LABS *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CDC LABS</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CDC LABS</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* U. S. PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>U. S. PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* U. S. PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>U. S. PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>It also provides the number of specimens tested for SARS CoV-2 by CDC labs and U. S. public health laboratories.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* KEY CDC LABORATORY ACTIVITIES *</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>KEY CDC LABORATORY ACTIVITIES *</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* KEY CDC LABORATORY ACTIVITIES</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>KEY CDC LABORATORY ACTIVITIES</pattern>
			<template>
				<random>
					<li>This page describes key CDC laboratory activities.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CLINICIANS *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CLINICIANS *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CLINICIANS</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CLINICIANS</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CRITERIA *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CRITERIA *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CRITERIA</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CRITERIA</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EVALUATION *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EVALUATION *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EVALUATION</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EVALUATION</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TESTING *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TESTING *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TESTING</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TESTING</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PRIORITIZATION CRITERIA *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PRIORITIZATION CRITERIA *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PRIORITIZATION CRITERIA</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PRIORITIZATION CRITERIA</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* REPORTING *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>REPORTING *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* REPORTING</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>REPORTING</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SPECIMEN COLLECTION *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SPECIMEN COLLECTION *</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SPECIMEN COLLECTION</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SPECIMEN COLLECTION</pattern>
			<template>
				<random>
					<li>This page provides clinicians with criteria to guide evaluation and testing for COVID-19 including prioritization criteria, and recommendations for reporting, testing, and specimen collection.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS REPOSITORY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS REPOSITORY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THIS REPOSITORY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THIS REPOSITORY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALLERGY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALLERGY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ALLERGY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ALLERGY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE NATIONAL INSTITUTES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE NATIONAL INSTITUTES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE NATIONAL INSTITUTES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE NATIONAL INSTITUTES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TOOLS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TOOLS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TOOLS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TOOLS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AGENTS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AGENTS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AGENTS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AGENTS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NON-PATHOGENIC MICROBES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NON-PATHOGENIC MICROBES *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NON-PATHOGENIC MICROBES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NON-PATHOGENIC MICROBES</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER MICROBIOLOGICAL MATERIALS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER MICROBIOLOGICAL MATERIALS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER MICROBIOLOGICAL MATERIALS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER MICROBIOLOGICAL MATERIALS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RELEVANCE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RELEVANCE *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RELEVANCE</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RELEVANCE</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE RESEARCH COMMUNITY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE RESEARCH COMMUNITY *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE RESEARCH COMMUNITY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE RESEARCH COMMUNITY</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DIAGNOSTIC DEVELOPERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DIAGNOSTIC DEVELOPERS *</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DIAGNOSTIC DEVELOPERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DIAGNOSTIC DEVELOPERS</pattern>
			<template>
				<random>
					<li>Several other federal agencies support this critical effort by providing: This repository was established by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to provide reagents, tools and information for studying agents, non-pathogenic microbes and other microbiological materials of relevance to the research community including diagnostic developers.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FDA *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FDA *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FDA</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FDA</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FAQS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FAQS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FAQS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FAQS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DIAGNOSTIC TESTING *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DIAGNOSTIC TESTING *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DIAGNOSTIC TESTING</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DIAGNOSTIC TESTING</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ANSWERS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ANSWERS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ANSWERS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ANSWERS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* QUESTIONS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>QUESTIONS *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* QUESTIONS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>QUESTIONS</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE DEVELOPMENT *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE DEVELOPMENT</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE DEVELOPMENT</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PERFORMANCE *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PERFORMANCE *</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PERFORMANCE</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PERFORMANCE</pattern>
			<template>
				<random>
					<li>FDA: FAQs on Diagnostic Testing for SARS-CoV-2 Provides answers to frequently asked questions relating to the development and performance of viral tests for SARS-CoV-2.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE U. S. DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE U. S. DEPARTMENT *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE U. S. DEPARTMENT</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE U. S. DEPARTMENT</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE ID *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE ID *</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE ID</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE ID</pattern>
			<template>
				<random>
					<li>The U. S. Department of Health and Human Services is purchasing the ID</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ASSOCIATION *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ASSOCIATION *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ASSOCIATION</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ASSOCIATION</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH LABORATORIES APHL *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH LABORATORIES APHL *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH LABORATORIES APHL</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH LABORATORIES APHL</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MEMBER LABORATORIES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MEMBER LABORATORIES *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MEMBER LABORATORIES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MEMBER LABORATORIES</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* QUALITY TESTING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>QUALITY TESTING *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* QUALITY TESTING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>QUALITY TESTING</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COMMUNICATIONS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COMMUNICATIONS *</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COMMUNICATIONS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COMMUNICATIONS</pattern>
			<template>
				<random>
					<li>Various other organizations are also supporting this critical effort by providing: Association of Public Health Laboratories APHL is supporting member laboratories during the COVID-19 pandemic by assisting with quality testing, reporting, technical assistance and communications.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LARGE-SCALE, RAPID GENOMIC SEQUENCING *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LARGE-SCALE, RAPID GENOMIC SEQUENCING *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LARGE-SCALE, RAPID GENOMIC SEQUENCING</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LARGE-SCALE, RAPID GENOMIC SEQUENCING</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COVID-19 RESPONSE CDC *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COVID-19 RESPONSE CDC *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE COVID-19 RESPONSE CDC</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE COVID-19 RESPONSE CDC</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH EXPERTS *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH EXPERTS *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH EXPERTS</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH EXPERTS</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IMPORTANT CHANGES *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IMPORTANT CHANGES *</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* IMPORTANT CHANGES</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>IMPORTANT CHANGES</pattern>
			<template>
				<random>
					<li>Large-scale, rapid genomic sequencing of the virus that causes the COVID-19 Response CDC will allow public health experts to Monitor important changes in the virus as it continues to circulate.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EXTENSIVE PARTICIPATION *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EXTENSIVE PARTICIPATION *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EXTENSIVE PARTICIPATION</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EXTENSIVE PARTICIPATION</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* US CLINICAL AND PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>US CLINICAL AND PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* US CLINICAL AND PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>US CLINICAL AND PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACADEMIC INSTITUTIONS *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACADEMIC INSTITUTIONS *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACADEMIC INSTITUTIONS</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACADEMIC INSTITUTIONS</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE PRIVATE SECTOR *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE PRIVATE SECTOR *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE PRIVATE SECTOR</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE PRIVATE SECTOR</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 MITIGATION STRATEGIES *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 MITIGATION STRATEGIES *</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 MITIGATION STRATEGIES</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 MITIGATION STRATEGIES</pattern>
			<template>
				<random>
					<li>With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AMD *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AMD *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* AMD</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>AMD</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE PAST SIX YEARS *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE PAST SIX YEARS *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE PAST SIX YEARS</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE PAST SIX YEARS</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FEDERAL, STATE, AND LOCAL PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FEDERAL, STATE, AND LOCAL PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FEDERAL, STATE, AND LOCAL PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FEDERAL, STATE, AND LOCAL PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PATHOGEN GENOMICS *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PATHOGEN GENOMICS *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PATHOGEN GENOMICS</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PATHOGEN GENOMICS</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER ADVANCED LABORATORY TECHNOLOGIES *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER ADVANCED LABORATORY TECHNOLOGIES *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OTHER ADVANCED LABORATORY TECHNOLOGIES</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OTHER ADVANCED LABORATORY TECHNOLOGIES</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INFECTIOUS DISEASE SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INFECTIOUS DISEASE SURVEILLANCE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INFECTIOUS DISEASE SURVEILLANCE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INFECTIOUS DISEASE SURVEILLANCE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OUTBREAK RESPONSE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OUTBREAK RESPONSE *</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OUTBREAK RESPONSE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OUTBREAK RESPONSE</pattern>
			<template>
				<random>
					<li>the SPHERES consortium is being led by the COVID-19 Response CDC’s Advanced Molecular Detection (AMD) program , which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SPHERES *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SPHERES *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SPHERES</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SPHERES</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* REAL-TIME PATHOGEN SEQUENCE DATA *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>REAL-TIME PATHOGEN SEQUENCE DATA *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* REAL-TIME PATHOGEN SEQUENCE DATA</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>REAL-TIME PATHOGEN SEQUENCE DATA</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOLECULAR EPIDEMIOLOGY *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOLECULAR EPIDEMIOLOGY *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MOLECULAR EPIDEMIOLOGY</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MOLECULAR EPIDEMIOLOGY</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE THE COVID-19 RESPONSE CDC PANDEMIC RESPONSE *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE THE COVID-19 RESPONSE CDC PANDEMIC RESPONSE *</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE THE COVID-19 RESPONSE CDC PANDEMIC RESPONSE</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE THE COVID-19 RESPONSE CDC PANDEMIC RESPONSE</pattern>
			<template>
				<random>
					<li>SPHERES aims to Accelerate the use of real-time pathogen sequence data and molecular epidemiology for the the COVID-19 Response CDC pandemic response.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* US CLINICAL, ACADEMIC, AND COMMERCIAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>US CLINICAL, ACADEMIC, AND COMMERCIAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* US CLINICAL, ACADEMIC, AND COMMERCIAL LABORATORIES</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>US CLINICAL, ACADEMIC, AND COMMERCIAL LABORATORIES</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SARS-COV-2 DATA *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SARS-COV-2 DATA *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SARS-COV-2 DATA</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SARS-COV-2 DATA</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ANY SCALE *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ANY SCALE *</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ANY SCALE</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ANY SCALE</pattern>
			<template>
				<random>
					<li>Better engage US clinical, academic, and commercial laboratories that are sequencing—or planning to sequence—SARS-CoV-2 data on any scale.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* 37 STATE AND LOCAL PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>37 STATE AND LOCAL PUBLIC HEALTH LABORATORIES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* 37 STATE AND LOCAL PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>37 STATE AND LOCAL PUBLIC HEALTH LABORATORIES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEVERAL LARGE REGIONAL AND NATIONAL CLINICAL DIAGNOSTIC CORPORATIONS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEVERAL LARGE REGIONAL AND NATIONAL CLINICAL DIAGNOSTIC CORPORATIONS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEVERAL LARGE REGIONAL AND NATIONAL CLINICAL DIAGNOSTIC CORPORATIONS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEVERAL LARGE REGIONAL AND NATIONAL CLINICAL DIAGNOSTIC CORPORATIONS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACADEMIC AND NON-PROFIT LEADERS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACADEMIC AND NON-PROFIT LEADERS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ACADEMIC AND NON-PROFIT LEADERS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ACADEMIC AND NON-PROFIT LEADERS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BIOINFORMATICS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BIOINFORMATICS *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BIOINFORMATICS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BIOINFORMATICS</pattern>
			<template>
				<random>
					<li>The SPHERES consortium includes 37 state and local public health laboratories, several large regional and national clinical diagnostic corporations, and academic and non-profit leaders in pathogen genomics, bioinformatics, and public health from across the country.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FEDERAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FEDERAL LABORATORIES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* FEDERAL LABORATORIES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>FEDERAL LABORATORIES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH AGENCIES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH AGENCIES *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH AGENCIES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH AGENCIES</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INTERNATIONAL GENOMICS EFFORTS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INTERNATIONAL GENOMICS EFFORTS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INTERNATIONAL GENOMICS EFFORTS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INTERNATIONAL GENOMICS EFFORTS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EFFORTS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EFFORTS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EFFORTS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EFFORTS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE GENOMICS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE GENOMICS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE GENOMICS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE GENOMICS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PATTERNS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PATTERNS *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PATTERNS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PATTERNS</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SARS-COV-2 TRANSMISSION *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SARS-COV-2 TRANSMISSION *</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SARS-COV-2 TRANSMISSION</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SARS-COV-2 TRANSMISSION</pattern>
			<template>
				<random>
					<li>Moreover, The SPHERES consortium aligns federal laboratories and public health agencies with international genomics efforts and engages the private sector in efforts to better understand the genomics and patterns of SARS-CoV-2 transmission across the United States.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* 8 CORE OBJECTIVES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>8 CORE OBJECTIVES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* 8 CORE OBJECTIVES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>8 CORE OBJECTIVES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A NETWORK *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A NETWORK *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A NETWORK</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A NETWORK</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING LABORATORIES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING LABORATORIES *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SEQUENCING LABORATORIES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SEQUENCING LABORATORIES</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BIOINFORMATICS CAPACITY *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BIOINFORMATICS CAPACITY *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BIOINFORMATICS CAPACITY</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BIOINFORMATICS CAPACITY</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUBJECT MATTER EXPERTISE *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUBJECT MATTER EXPERTISE *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SUBJECT MATTER EXPERTISE</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SUBJECT MATTER EXPERTISE</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE UMBRELLA *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE UMBRELLA *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE UMBRELLA</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE UMBRELLA</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A MASSIVE AND COORDINATED PUBLIC HEALTH SEQUENCING EFFORT *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A MASSIVE AND COORDINATED PUBLIC HEALTH SEQUENCING EFFORT *</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A MASSIVE AND COORDINATED PUBLIC HEALTH SEQUENCING EFFORT</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A MASSIVE AND COORDINATED PUBLIC HEALTH SEQUENCING EFFORT</pattern>
			<template>
				<random>
					<li>The SPHERES consortium has 8 core objectives: To bring together a network of sequencing laboratories, bioinformatics capacity and subject matter expertise under the umbrella of a massive and coordinated public health sequencing effort.</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A CONSORTIUM *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A CONSORTIUM *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* A CONSORTIUM</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>A CONSORTIUM</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE US PUBLIC HEALTH AND SCIENTIFIC COMMUNITY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE US PUBLIC HEALTH AND SCIENTIFIC COMMUNITY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE US PUBLIC HEALTH AND SCIENTIFIC COMMUNITY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE US PUBLIC HEALTH AND SCIENTIFIC COMMUNITY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CENTERS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CENTERS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CENTERS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CENTERS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DISEASE CONTROL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DISEASE CONTROL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DISEASE CONTROL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DISEASE CONTROL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PREVENTION *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PREVENTION *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PREVENTION</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PREVENTION</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OFFICE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OFFICE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OFFICE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OFFICE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADVANCED MOLECULAR DETECTION NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADVANCED MOLECULAR DETECTION NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADVANCED MOLECULAR DETECTION NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADVANCED MOLECULAR DETECTION NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GENOMICS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GENOMICS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* GENOMICS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>GENOMICS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADVANCED TECHNOLOGY NATIONAL INSTITUTES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADVANCED TECHNOLOGY NATIONAL INSTITUTES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADVANCED TECHNOLOGY NATIONAL INSTITUTES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADVANCED TECHNOLOGY NATIONAL INSTITUTES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NATIONAL HUMAN GENOME RESEARCH INSTITUTE NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NATIONAL HUMAN GENOME RESEARCH INSTITUTE NATIONAL INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NATIONAL HUMAN GENOME RESEARCH INSTITUTE NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NATIONAL HUMAN GENOME RESEARCH INSTITUTE NATIONAL INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDS *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* STANDARDS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>STANDARDS</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TECHNOLOGY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TECHNOLOGY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* TECHNOLOGY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>TECHNOLOGY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NATIONAL LIBRARY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NATIONAL LIBRARY *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NATIONAL LIBRARY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NATIONAL LIBRARY</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MEDICINE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MEDICINE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MEDICINE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MEDICINE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BIOTECHNOLOGY INFORMATION UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BIOTECHNOLOGY INFORMATION UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* BIOTECHNOLOGY INFORMATION UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>BIOTECHNOLOGY INFORMATION UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INFECTIOUS DISEASES​​ WALTER REED ARMY INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INFECTIOUS DISEASES​​ WALTER REED ARMY INSTITUTE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* INFECTIOUS DISEASES​​ WALTER REED ARMY INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>INFECTIOUS DISEASES​​ WALTER REED ARMY INSTITUTE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESEARCH STATE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESEARCH STATE *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* RESEARCH STATE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>RESEARCH STATE</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCAL PUBLIC HEALTH LABORATORIES MOUNT SINAI SCHOOL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCAL PUBLIC HEALTH LABORATORIES MOUNT SINAI SCHOOL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* LOCAL PUBLIC HEALTH LABORATORIES MOUNT SINAI SCHOOL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>LOCAL PUBLIC HEALTH LABORATORIES MOUNT SINAI SCHOOL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OREGON HEALTH AND SCIENCE UNIVERSITY NON-PROFIT PUBLIC HEALTH AND RESEARCH LABORATORIES ASSOCIATION *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OREGON HEALTH AND SCIENCE UNIVERSITY NON-PROFIT PUBLIC HEALTH AND RESEARCH LABORATORIES ASSOCIATION *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* OREGON HEALTH AND SCIENCE UNIVERSITY NON-PROFIT PUBLIC HEALTH AND RESEARCH LABORATORIES ASSOCIATION</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>OREGON HEALTH AND SCIENCE UNIVERSITY NON-PROFIT PUBLIC HEALTH AND RESEARCH LABORATORIES ASSOCIATION</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH LABORATORIES BILL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH LABORATORIES BILL *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* PUBLIC HEALTH LABORATORIES BILL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>PUBLIC HEALTH LABORATORIES BILL</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MELINDA GATES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MELINDA GATES *</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* MELINDA GATES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>MELINDA GATES</pattern>
			<template>
				<random>
					<li>SPHERES is a consortium of the US public health and scientific community that includes Centers for Disease Control and Prevention, Office of Advanced Molecular Detection National Institute of Allergy and Infectious Diseases, Office of Genomics and Advanced Technology National Institutes of Health, National Human Genome Research Institute National Institute of Standards and Technology National Library of Medicine, National Center for Biotechnology Information United States Army Medical Research Institute of Infectious Diseases​​ Walter Reed Army Institute of Research State and Local Public Health Laboratories Mount Sinai School of Medicine Oregon Health and Science University Non-Profit Public Health and Research Laboratories Association of Public Health Laboratories Bill and Melinda Gates</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADDITIONAL INFORMATION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADDITIONAL INFORMATION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADDITIONAL INFORMATION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADDITIONAL INFORMATION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE SARS-COV-2 SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE SARS-COV-2 SPHERES CONSORTIUM *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE SARS-COV-2 SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE SARS-COV-2 SPHERES CONSORTIUM</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CDC’S OFFICE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CDC’S OFFICE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* CDC’S OFFICE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>CDC’S OFFICE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADVANCED MOLECULAR DETECTION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADVANCED MOLECULAR DETECTION *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADVANCED MOLECULAR DETECTION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADVANCED MOLECULAR DETECTION</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 PRESS RELEASE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 PRESS RELEASE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* COVID-19 PRESS RELEASE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>COVID-19 PRESS RELEASE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NATIONAL VIRAL GENOMICS CONSORTIUM *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NATIONAL VIRAL GENOMICS CONSORTIUM *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NATIONAL VIRAL GENOMICS CONSORTIUM</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NATIONAL VIRAL GENOMICS CONSORTIUM</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SARS-COV-2 TRANSMISSION NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SARS-COV-2 TRANSMISSION NATIONAL CENTER *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SARS-COV-2 TRANSMISSION NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SARS-COV-2 TRANSMISSION NATIONAL CENTER</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EMERGING AND ZOONOTIC INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EMERGING AND ZOONOTIC INFECTIOUS DISEASES *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* EMERGING AND ZOONOTIC INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>EMERGING AND ZOONOTIC INFECTIOUS DISEASES</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NCEZID *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NCEZID *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* NCEZID</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>NCEZID</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADVANCED MOLECULAR DETECTION TESTING DATA *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADVANCED MOLECULAR DETECTION TESTING DATA *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* ADVANCED MOLECULAR DETECTION TESTING DATA</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>ADVANCED MOLECULAR DETECTION TESTING DATA</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE US SEROPREVALENCE SURVEYS *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE US SEROPREVALENCE SURVEYS *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* THE US SEROPREVALENCE SURVEYS</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>THE US SEROPREVALENCE SURVEYS</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SPECIAL POPULATIONS *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SPECIAL POPULATIONS *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* SPECIAL POPULATIONS</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>SPECIAL POPULATIONS</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOPING GUIDANCE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOPING GUIDANCE *</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>* DEVELOPING GUIDANCE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>DEVELOPING GUIDANCE</pattern>
			<template>
				<random>
					<li>To request additional information about the SARS-CoV-2 SPHERES consortium, including how to join, please email CDC’s Office of Advanced Molecular Detection at Information for Laboratories on COVID-19 Press Release: CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Office of Advanced Molecular Detection Testing Data in the US Seroprevalence Surveys in Special Populations Developing Guidance for Public Health</li>
					</random>
			</template>
		</category>
		<category>
			<pattern>*</pattern>
			<template>
				<think><set name="topic"><!-- No Topic --></set></think>
				Ok, changing topic.
			</template>
		</category>
	</topic>
</aiml>